KR20210081645A - Preparing method of highly functional peptide derived from natural fermentation extracts - Google Patents
Preparing method of highly functional peptide derived from natural fermentation extracts Download PDFInfo
- Publication number
- KR20210081645A KR20210081645A KR1020190173816A KR20190173816A KR20210081645A KR 20210081645 A KR20210081645 A KR 20210081645A KR 1020190173816 A KR1020190173816 A KR 1020190173816A KR 20190173816 A KR20190173816 A KR 20190173816A KR 20210081645 A KR20210081645 A KR 20210081645A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng fruit
- fermented
- functional peptide
- ginseng
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 51
- 238000000855 fermentation Methods 0.000 title claims abstract description 48
- 230000004151 fermentation Effects 0.000 title claims abstract description 48
- 239000000284 extract Substances 0.000 title abstract description 29
- 235000008434 ginseng Nutrition 0.000 claims abstract description 151
- 241000208340 Araliaceae Species 0.000 claims abstract description 146
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 145
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 145
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 115
- 239000002904 solvent Substances 0.000 claims abstract description 18
- 230000001965 increasing effect Effects 0.000 claims abstract description 11
- 238000005194 fractionation Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 60
- 239000002537 cosmetic Substances 0.000 claims description 41
- 230000000694 effects Effects 0.000 claims description 25
- 244000005700 microbiome Species 0.000 claims description 25
- 210000003491 skin Anatomy 0.000 claims description 21
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims description 15
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims description 15
- 102000029816 Collagenase Human genes 0.000 claims description 14
- 108060005980 Collagenase Proteins 0.000 claims description 14
- 235000021028 berry Nutrition 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 11
- 230000037303 wrinkles Effects 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 230000037319 collagen production Effects 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims description 7
- 240000004371 Panax ginseng Species 0.000 claims description 6
- 230000003712 anti-aging effect Effects 0.000 claims description 5
- 210000004927 skin cell Anatomy 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 210000002950 fibroblast Anatomy 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 2
- 210000002510 keratinocyte Anatomy 0.000 claims description 2
- 230000035755 proliferation Effects 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- 238000001542 size-exclusion chromatography Methods 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 13
- 108090000623 proteins and genes Proteins 0.000 abstract description 13
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- 210000004027 cell Anatomy 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000006071 cream Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 238000000746 purification Methods 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 13
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 239000002994 raw material Substances 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 229960002424 collagenase Drugs 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 244000063299 Bacillus subtilis Species 0.000 description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- -1 polyethylene Polymers 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 241000563903 Bacillus velezensis Species 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229930182494 ginsenoside Natural products 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 6
- 229940089161 ginsenoside Drugs 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- 241000186605 Lactobacillus paracasei Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000186610 Lactobacillus sp. Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000012223 aqueous fraction Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 2
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229940043348 myristyl alcohol Drugs 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000010480 babassu oil Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002037 dichloromethane fraction Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 108700038606 rat Smooth muscle Proteins 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 고 기능성 펩타이드 제조 방법에 관한 것으로, 보다 상세하게는 천연 발효물 유래 고 기능성 펩타이드 제조 방법에 관한 것이다.The present invention relates to a method for producing a high-functionality peptide, and more particularly, to a method for producing a high-functionality peptide derived from a natural fermented product.
발효는 미생물이 가지고 있는 효소가 원재료를 변화시켜 이로운 성분을 만들어내는 과정을 뜻한다. 발효 과정 중에는 유효 성분들이 추출되며 기능성 물질의 함량이 증가한다. 그리고, 발효기술은 생물전환, 생합성, 생촉매 등의 용어와 의미상 중복성을 가지며, 미생물이 갖고 있는 효소적 기능을 이용하여 전구물질로부터 원하는 산물을 제조하는 기술을 의미한다. 따라서, 생체기능을 세포 또는 효소 단계에서 이용하는 발효 기술은 유용물질 생산을 주요 목적으로 하여 현재의 생물공업을 구성하는 주요한 공정과정이라 할 수 있다.Fermentation refers to a process in which enzymes possessed by microorganisms change raw materials to produce beneficial ingredients. During the fermentation process, active ingredients are extracted and the content of functional substances increases. In addition, fermentation technology has overlap in meaning with terms such as bioconversion, biosynthesis, and biocatalyst, and refers to a technology for producing a desired product from a precursor by using the enzymatic function of a microorganism. Therefore, fermentation technology that uses biological functions in the cell or enzyme stage is a major process that constitutes the current biological industry with the main purpose of producing useful substances.
발효 식품이 자연적으로 발생하는 미생물을 활용하는 1차원적인 발효 기술을 활용했다면 발효 화장품은 더 앞선 기술을 필요로 한다. 또한, 단순히 전통적인 발효방법을 이용한 것이 1세대 발효라면 2세대 발효는 효능물질의 실용화 기술개발이었고, 유용한 생리활성 물질만을 대량으로 생산할 수 있는 고도의 발효생산기술을 통하여 화장품 기능성 소재산업의 기틀을 마련한 생물전환 발효 기술이 3세대 발효기술로서 자리매김하고 있다.If fermented food uses one-dimensional fermentation technology that utilizes naturally occurring microorganisms, fermented cosmetics require more advanced technology. In addition, if the first-generation fermentation simply used the traditional fermentation method, the second-generation fermentation was the development of practical technology for effective substances, and through advanced fermentation production technology that can produce only useful physiologically active substances in large quantities, the foundation of the cosmetic functional material industry was laid. Bioconversion fermentation technology is establishing itself as the third-generation fermentation technology.
우리나라 국민들은 김치, 된장 등 발효식품을 많이 이용하기 때문에 발효라는 개념이 매우 친숙하며 발효 원료를 이용한 화장품 역시 거부감 없이 사용하고 있다. 그리고 일반 대중에게도 발효기술을 이용하여 새로운 소재를 개발할 경우 기존 소재와 완전히 새로운 효능을 보이거나 유해한 많은 성분들이 안전한 성분으로 변화된다고 알려져 있어 발효 화장품에 대한 선호도가 높으며, 이에 따른 기술개발도 타 선진국에 비해 뒤지지 않는 수준이다. 하지만, 현재 화장품에 적용되는 많은 발효소재들이 천연발효 또는 자연숙성에 가까운 발효 방법을 사용하는 것으로 알려져 있다.Since Koreans use fermented foods such as kimchi and soybean paste a lot, the concept of fermentation is very familiar, and cosmetics using fermented raw materials are also used without objection. Also, the general public has a high preference for fermented cosmetics as it is known that when new materials are developed using fermentation technology, they show completely new effects from existing materials or that many harmful ingredients are changed into safe ingredients, and the technology development is also in other advanced countries. It is not inferior to the level. However, it is known that many fermented materials currently applied to cosmetics use natural fermentation or a fermentation method close to natural aging.
최근 국내 발효 기술의 연구 트랜드는 천연발효 또는 자연숙성에 가까운 발효 방법을 사용하는 것으로 알려져 있으며, 자연발효란 가공하지 않은 다양한 원료를 있는 그대로 두고 물과 바람, 대지, 계절 등 자연의 힘을 이용하여 피부에 유용한 성분을 자연스럽게 생산하는 방식으로, 비록 시간이 오래 걸리지만 다양한 물질들을 얻을 수 있어 보습과 항산화, 주름개선, 세포활성, 피부결 개선 등의 효과를 얻을 수 있다는 것이 강점이다. 그러나, 천연발효 또는 자연숙성 방식의 발효는 생산 배치(batch) 별로 일정한 품질의 발효생성물을 얻기 어려우며, 품질의 관리도 어려운 단점이 있다.The recent research trend in domestic fermentation technology is known to use natural fermentation or a fermentation method close to natural fermentation. Natural fermentation is a process that uses the power of nature such as water, wind, earth, and seasons while leaving various unprocessed raw materials as they are. It is a method that naturally produces ingredients useful for the skin, although it takes a long time. Its strength is that it can obtain various substances, so that it can obtain effects such as moisturizing, antioxidant, wrinkle improvement, cell activity, and skin texture improvement. However, fermentation of natural fermentation or natural aging method has disadvantages in that it is difficult to obtain a fermentation product of a certain quality for each production batch, and it is difficult to control the quality.
우리나라 발효화장품 시장은 최근 3~4년간 40%씩 고공성장을 거듭하고 있는 중이며, 2012년에는 약 4,500억 원, 2013년 약 6,500억 원, 2014년 약 1조 원(추정치) 규모를 달성할 것으로 전망하고 있다.The Korean fermented cosmetics market has been growing at a high rate of 40% in the last three to four years, and is expected to reach about 450 billion won in 2012, 650 billion won in 2013, and 1 trillion won (estimated) in 2014. is looking forward
발효물은 크게 발효여과물(Ferment Filtrate)과 발효용해물(Ferment Lysate)로 분류될 수 있는데, 발효여과물은 발효가 완료된 후 여과장치를 통해 미생물을 제거한 상등액(supernatant)을 활용하는 것이고, 발효용해물은 발효 완료 후 미생물을 열, pH, 효소(Lysozyme), 고압 등을 이용, 균을 사멸시켜 활용하는 방법이다.Fermented products can be largely classified into fermentation filtrates and fermentation lysates. Fermentation filtrates use a supernatant from which microorganisms are removed through a filtration device after fermentation is complete, and fermentation Lysate is a method in which microorganisms are killed by using heat, pH, enzymes (Lysozyme), high pressure, etc. after completion of fermentation.
한편, 인삼(Panax ginseng C.A.Meyer의 뿌리)은 전 세계적으로 각종 질병에 상용되는 전통적인 약재중의 하나로, 최근에는 항스트레스, 면역기능증강, 활력증진 그리고 항암작용을 하는 약재로 사용되고 있으며M 인삼의 대표적인 약리성분은 배당체의 하나인 사포닌(ginsenoside)으로, 현재까지 30여 가지의 진세노사이드가 있는 것으로 알려져 있다.On the other hand, ginseng (the root of Panax ginseng CAMeyer) is one of the traditional medicines used for various diseases worldwide. The pharmacological component is ginsenoside, which is one of glycosides, and it is known that there are about 30 types of ginsenoside so far.
최근 인삼의 항산화 효과, 항주름 효과, 피부노화 억제 효과가 있음이 알려지면서 현재에는 다양한 기능성을 가진 인삼 관련 미용관련 제품이 고가로 판매되고 있으며 그 수요도 점차 증가되고 있으나, 인삼은 그 세대기간이 4~6년으로 길며 6년을 재배하여야 1뿌리 당 100~150 g(fresh weight)의 수삼이 수확되고 연작이 불가능하다고 알려져 있다.Recently, as ginseng has been known to have antioxidant effects, anti-wrinkle effects, and anti-aging effects on the skin, ginseng-related beauty products with various functionalities are currently being sold at high prices and the demand for them is gradually increasing. It is 4-6 years long, and it is known that 100-150 g (fresh weight) of fresh ginseng per root can be harvested and continuous cultivation is impossible after 6 years of cultivation.
인삼 화장품의 경우 국내 소비자의 인삼에 대한 높은 선호도를 기반으로 오랜 기간동안 다양한 업체에서 해당 제품을 생산하여 왔고, 가장 대표적인 인삼화장품 제조 기업으로는 아모레퍼시픽사(상표명 설화수)과 한국담배인삼공사(상표명 동인비)가 대표적으로 손꼽히며, 각자 독자적인 제품군을 구축하여 소비자들의 좋은 반응을 받고 있다. 이들 기업들은 과거 인삼, 홍삼 추출액 등을 주요 성분으로 활용하였으나, 최근에는 사포닌이나 진세노사이드의 성분 만을 분리하여 처방하는 방식을 통해 품질을 개량하고 있으며, 국내의 소비자 외에 해외 수출을 통해 해외 고객들의 요구도 충족시키고 있다.In the case of ginseng cosmetics, various companies have been producing the product for a long time based on the high preference of domestic consumers for ginseng, and the most representative ginseng cosmetic manufacturers are Amorepacific (trade name: Sulwhasoo) and Korea Tobacco and Ginseng Corporation (trade name). Donginbi) is one of the representatives, and each has built its own product line and is receiving a good response from consumers. These companies used ginseng and red ginseng extract as main ingredients in the past, but recently they are improving the quality by separating and prescribing only the ingredients of saponin or ginsenoside. It also meets the needs.
인삼 부산물의 일종인 인삼열매(Ginseng berry)는 인삼에 비해 저렴한 가격으로 쉽게 구할 수 있는 원자재이나, 인삼 자체에 비해 뒤지지 않는 효능과 높은 함량으로 유효성분들이 함유되어 있다.Ginseng berry, a kind of ginseng by-product, is a raw material that can be easily obtained at a lower price than ginseng, but contains active ingredients with efficacy and high content comparable to that of ginseng itself.
인삼열매가 주목을 받기 시작한 것은 '진세노사이드 Re'라는 인삼열매의 독특한 사포닌이 당뇨병과 비만을 예방한다는 미국 시카고의대의 연구 결과가 2002년 미국 의학학술지 '당뇨병(Diabetes)'에 발표되면서이다. 연구팀이 당뇨병에 걸리게 조작한 쥐에게 인삼열매를 투여하자 공복 시 혈당 수치가 유의하게 감소됐다. 또한, 실험용 쥐의 콜레스테롤 수치와 체중이 감소했고 에너지 소비율은 증가함을 확인하였다.Ginseng fruit began to attract attention when the results of a study at the University of Chicago Medical School in the United States that the unique saponin of ginseng fruit called 'ginsenoside Re' prevents diabetes and obesity was published in the American medical journal Diabetes in 2002. When the research team administered ginseng berries to rats that were manipulated to become diabetic, fasting blood sugar levels were significantly reduced. In addition, it was confirmed that the cholesterol level and body weight of the experimental mice decreased and the energy consumption rate increased.
특히, 인삼열매는 주름을 개선하고 피부 탄력을 높이는 효과도 확인되었다. 인삼열매 내에는 항산화 효과가 뛰어난 비타민 E와 안토시아닌 성분이 풍부하게 함유돼 있어 노화 방지 효과가 인삼 뿌리보다 더 우수한 것으로 밝혀졌으며, 인삼열매 사포닌의 주 성분인 진세노사이드 Re는 식물성 에스트로겐과 비슷한 역할을 해 여성 갱년기 증상을 완화하는 데도 도움을 준다고 알려져 있다.In particular, the effect of ginseng berry improving wrinkles and enhancing skin elasticity was confirmed. The anti-aging effect was found to be superior to that of ginseng root because ginseng fruit contains abundant vitamin E and anthocyanin, which have excellent antioxidant effects. Ginsenoside Re, the main component of ginseng fruit saponin, has a similar role to phytoestrogens. It is also known to help relieve the symptoms of menopause in women.
인삼열매의 경우 유효성분을 다량 함유해 국내외에서 미용 재료, 제약 원료, 사료 첨가제 등으로 활용가능하며, 인삼 생산량 증가로 부산물 역시 증가 추세이고, 친환경 인삼 재배와 발효 기술 등이 발달하고, 부산물 활용의 제약 요인인 안전성 기준 완화로 산업 소재화 가능성이 증대하고 있는 상황이다. 인삼 부산물의 산업적 이용 가치를 고려해 다양한 용도와 응용방법 개발이 필요하며, 특히 기존에 잘 알려진 진세노사이드 계열 뿐만 아니라, 인삼열매내에 기능성 펩타이드에 대한 연구를 통해 인삼 부산물인 인삼열매의 효용성을 확대하는 연구의 필요성이 절실하다.In the case of ginseng fruit, because it contains a large amount of active ingredients, it can be used as a cosmetic ingredient, pharmaceutical raw material, and feed additive at home and abroad. The possibility of becoming an industrial material is increasing due to the relaxation of safety standards, a constraint factor. Considering the industrial use value of ginseng by-product, it is necessary to develop various uses and application methods. In particular, it is necessary to expand the utility of ginseng fruit, a by-product of ginseng, through research on functional peptides in the ginseng fruit as well as the well-known ginsenoside series. The need for research is urgent.
진세노사이드는 인삼의 주요 성분으로 의약품이나 건강기능 식품, 그리고 화장품의 기능성 성분으로 많이 활용되어 왔지만, 최근의 연구결과에 따르면 일부 진세노사이드에서 강한 세포독성이 발견되었다는 사실이 확인되면서 유해성 논란에 휩싸이게 되었다. 또한, Jin-Ho Chung 등(Food and Chemical Toxicology 118 (2018) 645.652)은 Rg3 배양액에 쥐의 평활근(내장의 벽을 구성하는 근육) 세포를 배양해 독성을 확인하였으며, Rg3 농도가 10 μM 이상인 배양액에서 심장 평활근 세포의 세포사(apoptosis)를 유발하였으며, 그 보다 농도가 낮은 1 μM에서도 평활근의 활동에 부정적인 영향을 확인하였으며, 그 메카니즘은 Rg3가 평활근 세포의 근육 수축·이완을 담당하는 'F-actin' 단백의 결합 상태를 무너뜨리고, F-actin에 결합한 'Bmf' 단백도 분리하여 유리된 Bmf 단백은 세포의 미토콘드리아로 이동하고, 미토콘드리아 내 에너지 생산활동을 방해해 세포사를 유도하게 되는 것으로 확인하였다. 따라서, 항암 효과가 있다고 알려진 Rg3에는 상당히 강한 세포 독성이 있으며, 암세포만을 선택적으로 죽이지 않고 정상 세포도 함께 파괴한다는 점을 논문을 통해 확인하였다.Ginsenoside is a major component of ginseng and has been widely used as a functional ingredient in pharmaceuticals, health functional foods, and cosmetics. became engulfed In addition, Jin-Ho Chung et al. (Food and Chemical Toxicology 118 (2018) 645.652) confirmed the toxicity by culturing rat smooth muscle (muscle composing the intestinal wall) cells in Rg3 culture medium, and culture medium with Rg3 concentration of 10 μM or more. induced apoptosis of cardiac smooth muscle cells, and the negative effect on smooth muscle activity was confirmed even at a lower concentration of 1 μM. The mechanism is that Rg3 is 'F-actin', which is responsible for muscle contraction and relaxation of smooth muscle cells. It was confirmed that 'Bmf protein, which was released by breaking down the binding state of the protein and also separating the 'Bmf' protein bound to F-actin, moves to the mitochondria of the cell and interferes with the energy production activity in the mitochondria to induce cell death. Therefore, it was confirmed through the paper that Rg3, which is known to have an anticancer effect, has a fairly strong cytotoxicity, and does not selectively kill only cancer cells but also destroys normal cells.
물론 인삼 내에는 Rg3 외에 다양한 진세노사이드가 존재하며 이들 모두의 독성을 확인한 것이 아니기 때문에 인삼이 인체에 유해하다고 생각할 수 없지만 현재 진세노사이드 일변도인 인삼유효 성분에서 벗어나 인삼의 다른 성분에 대한 연구가 필요한 것도 사실이다.Of course, there are various ginsenosides other than Rg3 in ginseng, and it cannot be considered that ginseng is harmful to the human body because the toxicity of all of them has not been confirmed. It is true that it is necessary.
인삼 혹은 인삼의 부산물에는 진세노사이드 외에 다양한 기능성 성분들이 있으며, 특히 인삼 다당체(Polysaccharides)의 면역 기능성에 대해서는 많은 연구가 이루어져 있다. 건강기능식품에서 인삼 다당체 추출물이 개별인증되어 활용되고 있으나, 인삼의 단백질이나 펩타이드에 대해서는 연구가 많이 부족한 것이 현실이며 인삼의 효능을 발휘하는 성분으로 파악되지 않은 상태이다.In addition to ginsenoside, ginseng or a byproduct of ginseng contains various functional ingredients, and in particular, a lot of research has been done on the immune function of ginseng polysaccharides. Although ginseng polysaccharide extract has been individually certified and used in health functional foods, the reality is that there is a lack of research on ginseng protein or peptide, and it has not been identified as an ingredient that exerts the efficacy of ginseng.
본 발명은 인삼열매 발효물 내 다양한 기능성을 갖는 펩타이드를 분리하는 방법과, 그 방법으로 분리되는 기능성 펩타이드를 유효성분으로 함유하는 화장료 조성물을 제공하고자 한다.An object of the present invention is to provide a method for isolating peptides having various functions in a fermented ginseng fruit, and a cosmetic composition containing the functional peptide separated by the method as an active ingredient.
상기 과제를 해결하기 위하여 본 발명은, 인삼열매(Panax Ginseng Berry)에 균을 접종 및 발효시킨 후 여과하여 미생물을 제거하는 단계를 포함하여 인삼열매 발효물 내 기능성 펩타이드를 분리하는 방법을 제공한다.In order to solve the above problems, the present invention provides a method for isolating functional peptides in fermented ginseng fruit, including the step of inoculating and fermenting ginseng fruit (Panax Ginseng Berry) with bacteria and then filtering to remove microorganisms.
또한, 상기 발효는 30 내지 50℃에서 2 내지 4일간 수행되는 것을 특징으로 하는 방법을 제공한다.In addition, the fermentation provides a method, characterized in that it is carried out at 30 to 50
또한, 상기 균은 바실러스 속(Bacullus sp.) 균인 것을 특징으로 하는 방법을 제공한다.In addition, the bacteria provides a method, characterized in that the bacteria of the genus Bacillus ( Bacullus sp.).
또한, 상기 기능성 펩타이드는 용매 분획 및 크기 배제 크로마토그래피를 통해 수득되는 것을 특징으로 하는 방법을 제공한다.In addition, the functional peptide provides a method, characterized in that obtained through solvent fractionation and size exclusion chromatography.
또한, 상기 기능성 펩타이드는 (글리신-알라닌)n(n은 2 내지 10의 정수)의 서열을 포함하는 것을 특징으로 하는 방법을 제공한다.In addition, the functional peptide provides a method, characterized in that it comprises a sequence of (glycine-alanine) n (n is an integer of 2 to 10).
또한, 상기 기능성 펩타이드는 글리신-알라닌-글리신-알라닌-글리신-알라닌의 서열을 포함하는 것을 특징으로 하는 방법을 제공한다.In addition, the functional peptide provides a method, characterized in that it comprises the sequence of glycine-alanine-glycine-alanine-glycine-alanine.
또한, 상기 기능성 펩타이드는 피부 주름 개선 및 항노화 기능을 갖는 것을 특징으로 하는 방법을 제공한다.In addition, the functional peptide provides a method, characterized in that it has skin wrinkle improvement and anti-aging functions.
또한, 상기 기능성 펩타이드는 피부세포 생장을 촉진하여 피부세포의 재생속도를 증가시키는 기능을 갖는 것을 특징으로 하는 방법을 제공한다.In addition, the functional peptide provides a method characterized in that it has a function of increasing the skin cell regeneration rate by promoting skin cell growth.
또한, 상기 기능성 펩타이드는 인간 섬유아세포주 내 콜라겐 생성을 촉진하고, 콜라겐 분해효소(MMP-1)의 활성을 억제하여 피부 주름 개선 기능을 갖는 것을 특징으로 하는 방법을 제공한다.In addition, the functional peptide promotes collagen production in human fibroblasts and inhibits the activity of collagen degrading enzyme (MMP-1) to provide a method characterized in that it has a skin wrinkle improvement function.
또한, 상기 인삼열매 발효물 및 상기 기능성 펩타이드는 인간 피부 각질 세포주 증식 촉진 기능을 갖는 것을 특징으로 하는 방법을 제공한다.In addition, the fermented ginseng fruit and the functional peptide provide a method, characterized in that it has a function of promoting the proliferation of human skin keratinocytes.
상기 또 다른 과제를 해결하기 위하여 본 발명은, 상기 방법에 따라 분리된 기능성 펩타이드를 유효성분으로 함유하는 화장료 조성물을 제공한다.In order to solve the another problem, the present invention provides a cosmetic composition containing the functional peptide isolated according to the above method as an active ingredient.
본 발명은 인삼열매의 발효를 통해 인삼열매 내 단백질과 펩타이드의 패턴이 전환되는 것을 확인하였으며, 또한, 분리정제를 통해 펩타이드 함량이 증가될수록 높은 주름 개선 활성을 보이는 것도 확인하였다. 특히, 우수한 효능을 보이는 펩타이드를 최종적으로 분리하여 단일 펩타이드의 독성, 효능, 물성 등을 확인하였다.The present invention confirmed that the pattern of proteins and peptides in the ginseng fruit was converted through fermentation of the ginseng fruit, and it was also confirmed that the higher the peptide content through the separation and purification, the higher the anti-wrinkle activity. In particular, peptides showing excellent efficacy were finally isolated and the toxicity, efficacy, and physical properties of a single peptide were confirmed.
본 발명을 통해 제공되는 인삼열매로부터 유래된 기능성 펩타이드는 화장품 조성물로서 다양한 활용성을 가질 수 있다.The functional peptide derived from ginseng fruit provided through the present invention may have various uses as a cosmetic composition.
도 1은 본 발명에 따른 인삼열매 발효 정제물의 제조 과정을 나타낸 모식도,
도 2는 본 발명의 실험예 2의 인삼열매 발효물 분획 후 단백질 정량 결과를 나타낸 그래프,
도 3은 본 발명의 실험예 3의 인삼열매 발효물 컬럼 분리 정제 후 TLC 결과를 촬영한 사진,
도 4는 본 발명의 실험예 4의 인삼열매 발효물 컬럼 분리 정제 후 단백질 함량 확인 결과를 나타낸 그래프,
도 5은 본 발명의 실험예 5의 인삼열매 발효물의 정제 단계 별 target peptide 함량 확인 결과를 나타낸 그래프,
도 6은 본 발명에 따른 고성능 액상 크로마토그래피 분석 결과를 나타낸 그래프(Gly-Ala-Gly-Ala-Gly-Ala),
도 7은 본 발명에 따른 실험예 6의 인삼열매 펩타이드(ApepHexapeptide-01) NMR 및 FAB-mass 분석 결과를 나타낸 그래프(Gly-Ala-Gly-Ala-Gly-Ala),
도 8는 본 발명의 실험예 8의 인삼열매 추출, 발효 분획물의 MMP-1 저해능 측정 결과를 나타낸 그래프,
도 9은 본 발명의 실험예 9의 인삼열매 발효물, 분획물, 정제물의 세포 내 콜라겐 생성 촉진효과 결과를 나타낸 그래프,
도 10 및 도 11 본 발명의 실험예 10(인삼열매 정제물)의 세포 증식능을 3T3 세포 및 HACAT 세포에서 측정한 결과를 나타낸 그래프,
도 12 및 도 13는 본 발명의 Hexapeptide AP-1의 광 안정성 및 열 안정성 측정 결과를 나타낸 그래프.1 is a schematic diagram showing the manufacturing process of fermented ginseng fruit purified product according to the present invention;
2 is a graph showing the protein quantification results after fractionation of the fermented ginseng fruit of Experimental Example 2 of the present invention;
3 is a photograph of TLC results after column separation and purification of ginseng fruit fermentation product of Experimental Example 3 of the present invention;
4 is a graph showing the protein content confirmation result after column separation and purification of the ginseng fruit fermentation product of Experimental Example 4 of the present invention;
5 is a graph showing the results of confirming the target peptide content for each purification step of the fermented ginseng fruit of Experimental Example 5 of the present invention;
6 is a graph showing the results of high performance liquid chromatography analysis according to the present invention (Gly-Ala-Gly-Ala-Gly-Ala);
7 is a graph showing the results of NMR and FAB-mass analysis of ginseng berry peptide (ApepHexapeptide-01) of Experimental Example 6 according to the present invention (Gly-Ala-Gly-Ala-Gly-Ala);
8 is a graph showing the MMP-1 inhibitory ability measurement results of ginseng fruit extraction and fermentation fractions of Experimental Example 8 of the present invention;
9 is a graph showing the results of the fermented ginseng fruit, fractions, and purified products of Experimental Example 9 of the present invention, the results of promoting intracellular collagen production;
10 and 11 A graph showing the results of measuring the cell proliferation ability of Experimental Example 10 (ginseng fruit purified product) of the present invention in 3T3 cells and HACAT cells;
12 and 13 are graphs showing the optical stability and thermal stability measurement results of Hexapeptide AP-1 of the present invention.
이하, 실시예를 통하여 본 발명을 상세히 설명하기로 한다. 이에 앞서, 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여, 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 명세서에 기재된 실시예의 구성은 본 발명의 가장 바람직한 일실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원 시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.Hereinafter, the present invention will be described in detail through examples. Prior to this, the terms or words used in the present specification and claims should not be construed as being limited to their ordinary or dictionary meanings, and the inventor should properly understand the concept of the term in order to best describe his invention. Based on the principle that can be defined, it should be interpreted as meaning and concept consistent with the technical idea of the present invention. Accordingly, since the configuration of the embodiments described in the present specification is only the most preferred embodiment of the present invention and does not represent all the technical spirit of the present invention, various equivalents and modifications that can be substituted for them at the time of the present application It should be understood that there may be
본 발명자들은 피부노화 및 주름을 효과적으로 방지 또는 개선하기 위해서 항산화 효능이 확인된 원료와 피부 노화 방지에 효과가 있는 화장료 조성물을 개발하기 위하여 연구를 거듭한 결과, 인삼열매 열매 추출물을 발효시키거나, 인삼열매 발효물에서 유래된 펩타이드를 사용하는 경우, 콜라겐 분해 효소(Matrix Metalloproteinase-1)의 활성 저해, 세포 내 콜라겐 생성 촉진 및 표피 세포 증식 촉진 효능을 향상시킬 수 있음을 발견하고 본 발명에 이르게 되었다.As a result of repeated research to develop a cosmetic composition effective in preventing skin aging and raw materials with an antioxidant effect in order to effectively prevent or improve skin aging and wrinkles, the present inventors have fermented ginseng fruit extract, or ginseng It has been found that, when a peptide derived from a fermented fruit is used, it is possible to improve the effect of inhibiting the activity of a collagen degrading enzyme (Matrix Metalloproteinase-1), promoting intracellular collagen production, and promoting epidermal cell proliferation, leading to the present invention.
따라서, 본 발명은 인삼열매 발효물 또는 인삼열매 발효 정제물을 유효성분으로 포함하는 화장료 조성물의 제공을 위한 방법으로, 인삼열매(Panax Ginseng Berry)에 균을 접종 및 발효시킨 후 여과하여 미생물을 제거하는 단계를 포함하여 인삼열매 발효물 내 기능성 펩타이드를 분리하는 방법을 개시한다.Accordingly, the present invention is a method for providing a cosmetic composition comprising a fermented ginseng fruit or a fermented ginseng fruit as an active ingredient, inoculating and fermenting ginseng fruit (Panax Ginseng Berry) with bacteria and then filtering to remove microorganisms Disclosed is a method for isolating a functional peptide in a fermented ginseng fruit.
본 발명에서 상기 인삼열매(Panax ginseng Berry)는 두릅나무과에 속하는 여러해살이풀이며, 약용으로 많이 재배되고 있다. 상기 인삼열매는 4년생 이상의 인삼에서만 열리며 다양한 약리 작용이 밝혀져 있으며, 화장료로 개발되어 피부미용과 노화방지를 위해 활용되고 있다.In the present invention, the ginseng fruit (Panax ginseng Berry) is a perennial plant belonging to the Araliaceae family, and is widely cultivated for medicinal purposes. The ginseng fruit is opened only in ginseng aged 4 years or older, and various pharmacological actions have been revealed, and it has been developed as a cosmetic and used for skin beauty and anti-aging.
본 발명에서 상기 인삼열매 발효물은 인삼열매를 건조, 추출한 후 발효한 발효물을 의미하며, 인삼열매 추출물은 다양한 질환에 효과가 있는 약재로 활용되었고, 사포닌 등의 다양한 효능을 가진 성분이 풍부하여 항암, 항산화, 항암, 간질환 개선 등의 효능이 확인되고 있는 약제이다.In the present invention, the fermented ginseng fruit refers to a fermented product after drying and extracting ginseng fruit, and the ginseng fruit extract has been used as a drug effective for various diseases, and is rich in ingredients having various effects such as saponins. It is a drug whose efficacy has been confirmed such as anti-cancer, antioxidant, anti-cancer, and liver disease improvement.
본 발명의 인삼열매 발효물 또는 인삼열매 발효 정제물은 피부에 작용하여, 피부 주름 개선, 피부 노화 완화에 도움을 주는 원료이며, 효능이 있는 특정 성분을 정제함으로 정제 전과 비교하여 그 효과가 더욱 증강될 수 있으며, 인삼열매 발효물 및 인삼열매 발효 정제물을 함께 사용할 수 있다.The fermented ginseng fruit or fermented ginseng fruit of the present invention is a raw material that acts on the skin to help improve skin wrinkles and alleviate skin aging, and by refining specific effective ingredients, the effect is further enhanced compared to before purification It can be used, and the fermented ginseng fruit and the fermented ginseng fruit can be used together.
본 발명은 일 양태로서 인삼열매 발효물 내 기능성 펩타이드를 분리하는 방법을 제공하고, 상기 인삼열매 발효물 내 기능성 펩타이드를 분리하는 방법은 인삼열매(Panax Ginseng Berry)에 균을 접종 및 발효시킨 후 여과하여 미생물을 제거하는 단계를 포함한다.In one aspect, the present invention provides a method for isolating a functional peptide in a fermented ginseng fruit, and the method for isolating a functional peptide in a fermented ginseng fruit is a ginseng fruit (Panax Ginseng Berry) inoculated and fermented with bacteria, followed by filtration to remove microorganisms.
이하 상기 인삼열매 발효물 제조방법을 통해 본 발명을 자세히 설명한다.Hereinafter, the present invention will be described in detail through the method for producing the fermented ginseng fruit.
본 발명에서 상기 인삼열매 열매 추출물에 미생물을 접종하고 발효시켜 발효물을 제조하는 단계는 인삼열매 열매의 기능성 물질의 함량을 증가시키기 위한 단계이다.In the present invention, the step of inoculating the ginseng fruit extract with microorganisms and fermenting it to prepare a fermented product is a step for increasing the content of functional substances in the ginseng fruit fruit.
상기 인삼열매 열매 추출물은 당업계에 공지된 통상의 추출 방법, 예를 들어 용매 추출법을 사용하여 제조될 수 있다. 용매 추출법을 이용한 혼합 추출물 제조시 사용되는 추출 용매는 물, 탄소 수가 1 내지 4인 저급 알코올(예를 들면, 메탄올, 에탄올, 프로판올 및 부탄올) 또는 이들의 혼합물인 함수 저급 알코올, 프로필렌글리콜, 1,3-부틸렌글리콜, 글리세린, 아세톤, 디에틸에테르, 에틸아세테이트, 부틸아세테이트, 디클로로메탄, 디클로로메탄, 헥산 및 이들의 혼합물로 구성된 군으로부터 선택될 수 있고, 이중 물, 알코올 또는 이들의 혼합물에서 선택되는 것이 바람직하며, 추출 용매로 알코올을 사용하는 경우 알코올은 탄소 수가 1 내지 4인 저급알코올인 것이 바람직하고, 저급 알코올은 메탄올 또는 에탄올에서 선택되는 것이 더 바람직하며, 더욱 더 바람직하게는 에탄올일 수 있다.The ginseng fruit extract may be prepared using a conventional extraction method known in the art, for example, a solvent extraction method. The extraction solvent used in the preparation of the mixed extract using the solvent extraction method is water, a lower alcohol having 1 to 4 carbon atoms (eg, methanol, ethanol, propanol and butanol) or a mixture thereof, which is a hydrous lower alcohol, propylene glycol, 1, 3-butylene glycol, glycerin, acetone, diethyl ether, ethyl acetate, butyl acetate, dichloromethane, dichloromethane, hexane, and mixtures thereof may be selected from the group consisting of, and selected from water, alcohol, or mixtures thereof When alcohol is used as the extraction solvent, the alcohol is preferably a lower alcohol having 1 to 4 carbon atoms, and the lower alcohol is more preferably selected from methanol or ethanol, and even more preferably ethanol. have.
또한, 상기 인삼열매 열매 추출물을 에탄올로 추출하는 경우, 예를 들어, 99.5%(v/v) 에탄올을 인삼열매의 5 내지 20배 중량으로 첨가하고, 상온에서 18 내지 30시간 동안 추출할 수 있고, 상기 인삼열매 추출물의 당도는 4 내지 10 brix, 바람직하게는 6 내지 8 birx일 수 있다.In addition, when the ginseng fruit extract is extracted with ethanol, for example, 99.5% (v/v) ethanol is added in an
또한, 상기 인삼열매 추출물을 열수 추출로 추출하는 경우, 예를 들어, 정제수를 인삼열매 열매의 5 내지 20배 중량으로 첨가하고, 100 내지 140℃로 4 내지 8시간 동안 추출할 수 있으며, 상기 인삼열매 열매 추출물의 당도는 4 내지 10 brix, 바람직하게는 6 내지 8 birx일 수 있다.In addition, when the ginseng fruit extract is extracted by hot water extraction, for example, purified water may be added at 5 to 20 times the weight of the ginseng fruit, and extracted at 100 to 140° C. for 4 to 8 hours, the ginseng The sugar content of the fruit extract may be 4 to 10 brix, preferably 6 to 8 birx.
본 발명에서 상기 미생물은 바실러스 속(Bacillus sp.) 균주, 락토바실러스 속(Lactobacillus sp.) 균주 또는 이들의 혼합 균주로 발효될 수 있으며, 상기 바실러스 속(Bacillus sp.) 균주는 바실러스 메틸로트로피쿠스(Bacillus methylotrophicus) 또는 바실러스 서브틸리스(Bacillus subtilis)일 수 있고, 상기 락토바실러스 속(Lactobacillus sp.) 균주는 락토바실러스 파라카세이(Lactobacillus paracasei)일 수 있고, 바람직하게는 바실러스 서브틸리스 및 바실러스 메틸로트로피쿠스의 혼합 균주일 수 있다.In the present invention, the microorganism may be fermented into a Bacillus sp. strain, a Lactobacillus sp. strain or a mixed strain thereof, and the Bacillus sp. strain is Bacillus methylotropicus ( Bacillus methylotrophicus ) or Bacillus subtilis ( Bacillus subtilis ), the Lactobacillus genus ( Lactobacillus sp.) strain may be Lactobacillus paracasei ( Lactobacillus paracasei ), preferably Bacillus subtilis and Bacillus methyl It may be a mixed strain of Rotropicus.
상기 발효란 미생물이 가지고 있는 효소가 원재료를 변화시켜 이로운 성분을 만들어내는 과정을 말하며, 발효 과정 중에는 유효 성분들이 추출되며 기능성 물질의 함량이 증가한다. 또한, 본 발명에서 상기 발효는 상기 미생물 균주의 배양액을 107 내지 1010 cfu/㎖로 조절하여, 상기 인삼열매 열매 추출물에 대하여 0.1 내지 10 중량%, 바람직하게는 0.5 내지 5 중량%를 접종할 수 있고, 1 내지 5일, 바람직하게는 2 내지 4일 동안, 25 내지 45℃, 바람직하게는 30 내지 40℃에서 수행될 수 있다.The fermentation refers to a process in which enzymes possessed by microorganisms change raw materials to create beneficial ingredients, and during the fermentation process, active ingredients are extracted and the content of functional substances increases. In addition, in the present invention, the fermentation is performed by adjusting the culture medium of the microorganism strain to 10 7 to 10 10 cfu/ml, and inoculating 0.1 to 10% by weight, preferably 0.5 to 5% by weight of the ginseng fruit extract. and may be carried out at 25 to 45 °C, preferably 30 to 40 °C, for 1 to 5 days, preferably 2 to 4 days.
또한, 상기 미생물 배양 및 발효 시 배지 조성은 글루코오스 0.2 내지 1 중량%, 효소 추출물 0.1 내지 0.5 중량%, 소이톤(soytone) 0.05ㅍ0.3 중량% 및 증류수(잔량)일 수 있다.In addition, the composition of the medium for culturing and fermenting the microorganisms may be glucose 0.2 to 1% by weight, enzyme extract 0.1 to 0.5% by weight, soytone 0.05% by weight, and distilled water (residual amount).
본 발명에서 상기 발효물에서 상기 미생물을 제거하여 인삼열매 발효물을 제조하는 단계는 인삼열매 발효물의 추가 발효를 방지하기 위해 미생물을 제거하는 단계로서, 상기 미생물 제거는 원심분리 및 여과를 통해 제거될 수 있으며, 예를 들어, 상기 발효물을 원심분리기를 통해 미생물을 분리한 후, 0.1 내지 0.3 ㎛ 필터로 여과하여 미생물을 제거할 수 있다.In the present invention, the step of preparing a fermented ginseng fruit by removing the microorganism from the fermented product is a step of removing microorganisms to prevent further fermentation of the fermented ginseng fruit, and the microorganism removal is to be removed through centrifugation and filtration. For example, after separating the microorganisms through a centrifuge in the fermented product, it is possible to remove the microorganisms by filtering with a 0.1 to 0.3 μm filter.
도 1은 본 발명에 따른 인삼열매 발효 정제물의 제조 과정을 나타낸 모식도이다.1 is a schematic diagram showing the manufacturing process of fermented ginseng fruit purified product according to the present invention.
도 1을 참조하면, 인삼열매 발효물을 용매 분획하는 단계는 인삼열매 발효물을 정제하여 펩타이드를 추출하는 단계로서 상기 용매 분획은 헥산, 디클로로메탄, 에틸아세테이트, 부탄올 및 물을 통해 순차적으로 수행될 수 있다. 또한, 상기 용매 분획 후 컬럼을 통해 정제할 수 있다.1 , the solvent fractionation of the fermented ginseng fruit is a step of extracting peptides by purifying the fermented ginseng fruit. The solvent fractionation is sequentially performed through hexane, dichloromethane, ethyl acetate, butanol and water. can In addition, it may be purified through a column after the solvent fractionation.
또한, 본 발명에서 상기 인삼열매 발효 정제물은 인삼열매에서 유래된 헥사 펩타이드(Hexapeptide)일 수 있고, 상기 헥사 펩타이드는 글리신(Glycine, Gly)-알라닌(Alanine, Ala)-글리신(Glycine, Gly)-알라닌(Alanine, Ala)-글리신(Glycine, Gly)-알라닌(Alanine, Ala)일 수 있다.In addition, in the present invention, the fermented product of ginseng fruit may be a hexapeptide derived from ginseng fruit, and the hexapeptide is glycine (Glycine, Gly)-alanine (Alanine, Ala)-glycine (Glycine, Gly) -alanine (Alanine, Ala) -glycine (Glycine, Gly) - may be alanine (Alanine, Ala).
본 발명에서 상기 화장료 조성물은 상기 인삼열매 발효물 또는 상기 인삼열매 발효 정제물을 1 내지 90 중량% 포함할 수 있고, 바람직하게는 1 내지 20 중량% 포함할 수 있다. 또한, 상기 화장료 조성물은 상기 인삼열매 발효물 및 상기 인삼열매 발효 정제물을 포함할 수 있고, 각각 1 내지 20 중량% 포함할 수 있다.In the present invention, the cosmetic composition may contain 1 to 90% by weight of the fermented ginseng fruit or the purified ginseng fruit, preferably 1 to 20% by weight. In addition, the cosmetic composition may include the fermented ginseng fruit and the fermented ginseng fruit, and may contain 1 to 20% by weight, respectively.
본 발명에 따른 화장료 조성물은 콜라게나제, MMP-1(Matrix Metalloproteinase-1)과 같은 콜라겐 분해 효소의 활성을 저해하는 효과가 매우 우수한 것으로 확인이 되었으며, 또한 세포 내 콜라겐 생성을 촉진하는 효과와 피부세포의 재생능을 향상시키는 효과 또한 매우 우수한 것으로 확인되었다.It was confirmed that the cosmetic composition according to the present invention has a very excellent effect of inhibiting the activity of collagen-degrading enzymes such as collagenase and MMP-1 (Matrix Metalloproteinase-1), and also has an effect of promoting intracellular collagen production and skin It was also confirmed that the effect of improving the regenerative capacity of cells was very good.
본 발명에 따른 상기 화장료 조성물은 젤 타입, 스킨 타입, 크림 타입, 연고 타입 등으로 적용될 수 있지만, 이들만으로 한정되는 것은 아니다. 상기의 조성물은 그것의 타입에 따라 적절한 통상의 연화제, 유화제, 증점제 또는 당업계에 공지되어 있는 기타 물질들을 첨가하여, 공지의 방법에 의해 적절하게 제조될 수 있다.The cosmetic composition according to the present invention may be applied in a gel type, a skin type, a cream type, an ointment type, etc., but is not limited thereto. The above composition can be suitably prepared by a known method by adding an appropriate conventional softening agent, emulsifying agent, thickening agent or other substances known in the art according to its type.
상기 젤 타입 조성물은 트리메틸올프로판, 폴리에틸렌 글리콜 또는 글리세린 등의 연화제, 프로필렌 글리콜, 에탄올, 이소세틱알콜 등의 용매, 정제주 등을 첨가하여 제조할 수 있다.The gel-type composition may be prepared by adding an emollient such as trimethylolpropane, polyethylene glycol, or glycerin, a solvent such as propylene glycol, ethanol, or isostatic alcohol, and purified alcohol.
상기 스킨 타입 조성물은 스테아릴 알콜, 미리스틸 알콜, 베헤닐 알콜, 아라키딜 알콜, 이소스테아릴 알콜, 이소세틸 알콜 등의 지방 알콜, 부틸렌 글라이콜, 글리세린, 알란토인, 메틸 파라벤, 이디티에이-2-소디움, 잔탄검, 디메티콘, 폴리 에틸렌 글라이콜-60 하이드로제네이트 카스톨 오일, 폴리 소르베이트 60 및 정제수 등을 첨가하여 제조할 수 있다.The skin type composition includes fatty alcohols such as stearyl alcohol, myristyl alcohol, behenyl alcohol, arachidyl alcohol, isostearyl alcohol, isocetyl alcohol, butylene glycol, glycerin, allantoin, methyl paraben, EDTA- It can be prepared by adding 2-sodium, xanthan gum, dimethicone, polyethylene glycol-60 hydrogenated castol oil,
상기 크림 타입 조성물은 스테아릴 알콜, 미리스틸 알콜, 베헤닐 알콜, 아라키딜 알콜, 이소스테아릴 알콜, 이소세틸 알콜 등의 지방 알콜, 레시틴, 포스파티딜콜린, 포스파티딜에탄올아민, 소프파티질세린, 소프파티딜이노시톨 등의 리피드, 이들의 유도체, 글리세릴 스테아레이트, 소르비탄 팔미테이트, 소리비탄 스테아레이트 등의 유화제, 아보카도 오일, 살구 오일, 바바수 오일, 유리지치 오일, 동백 오일 등의 천연 지방 또는 오일, 프로필렌글리콜 등의 용매 및 정제수 등을 첨가하여 제조할 수 있다.The cream-type composition comprises fatty alcohols such as stearyl alcohol, myristyl alcohol, behenyl alcohol, arachidyl alcohol, isostearyl alcohol, isocetyl alcohol, lecithin, phosphatidylcholine, phosphatidylethanolamine, sofatizylserine, sofphatidyl Lipids such as inositol, derivatives thereof, emulsifiers such as glyceryl stearate, sorbitan palmitate, and sorbitan stearate, natural fats or oils such as avocado oil, apricot oil, babassu oil, lucidium oil, camellia oil, It can be prepared by adding a solvent such as propylene glycol and purified water.
상기 연고 타입 조성물은 연화제, 유화제 및 마이크로크리스탈린납, 파라핀, 세레신, 밀납, 경납, 바세린 등의 왁스를 첨가하여 제조할 수 있다.The ointment-type composition may be prepared by adding a softening agent, an emulsifying agent, and waxes such as microcrystalline lead, paraffin, ceresin, beeswax, beeswax, and vaseline.
본 발명의 화장료 조성물은 유효성분 이외에 추가로 동일 또는 유사한 기능을 나타내는 피부 주름개선 성분을 1종 이상 추가로 함유할 수 있다. 피부주름개선 성분으로는 비타민 C, 레티노산, TGF, 동물 태반 유래의 단백질, 베튤린산 및 클로렐라 추출물로 구성되는 군으로부터 선택되는 어느 하나 이상인 것일 수 있으나, 이에 제한되는 것은 아니다. 또한, 본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain one or more skin wrinkle-improving ingredients exhibiting the same or similar function in addition to the active ingredient. The skin wrinkle improvement component may be any one or more selected from the group consisting of vitamin C, retinoic acid, TGF, animal placental-derived protein, betulinic acid, and chlorella extract, but is not limited thereto. In addition, the cosmetic composition of the present invention may further contain excipients including fluorescent substances, fungicides, hydrotropes, humectants, fragrances, fragrance carriers, proteins, solubilizers, sugar derivatives, sunscreens, vitamins, plant extracts, etc. can
본 발명에서 상기 화장료 조성물은 유연화장수, 수렴화장수, 영양화장수, 아이크림, 세럼, 영양크림, 맛사지크림, 클렌징크림, 클렌징로션, 클렌징폼, 클렌징워터, 파우더, 엣센스, 팩, 헤어토닉, 헤어트리트먼트, 샴푸 또는 린스로 제형화될 수 있다.In the present invention, the cosmetic composition is a softening lotion, astringent lotion, nourishing lotion, eye cream, serum, nourishing cream, massage cream, cleansing cream, cleansing lotion, cleansing foam, cleansing water, powder, essence, pack, hair tonic, hair treatment It may be formulated as a conditioner, shampoo or rinse.
상기 화장료 조성물은 통상의 방법에 의해 제형화될 수 있다. 피부 외용제의 제형화에 있어서 Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA에 개시되어 있는 내용을 참조할 수 있고, 화장료 조성물의 제형화에 있어서 International cosmetic ingredient dictionary, 6th ed(The cosmetic, Toiletry and Fragrance Association, Inc, Washington, 1995)에 개시되어 있는 내용을 참조할 수 있다.The cosmetic composition may be formulated by a conventional method. In the formulation of external skin preparations, reference may be made to the contents disclosed in Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA, and in the formulation of cosmetic compositions, the International cosmetic ingredient dictionary, 6th ed (The cosmetic, Toiletry and Fragrance Association) , Inc, Washington, 1995) may be referred to.
구체적으로, 상기 화장료 조성물은 일반적인 유화 제형 및 가용화 제형으로 제조할 수 있다. 예컨대, 유연 화장수 또는 영양 화장수 등의 화장수; 훼이셜 로션, 바디로션 등의 유액; 영양 크림, 수분 크림, 아이 크림 등의 크림; 에센스; 화장연고; 스프레이; 젤; 팩; 선 스크린; 메이크업 베이스; 액체 타입, 고체 타입 또는 스프레이 타입 등의 파운데이션; 파우더; 클렌징 크림, 클렌징 로션, 클렌징 오일 등의 메이크업 제거제; 또는 클렌징 폼, 비누, 바디워시 등의 세정제로 제형화될 수 있으나 이에 한정되는 것은 아니다. 또한 상기 피부 외용제는, 연고, 패취, 겔, 크림 또는 분무제로 제형화될 수 있으나 이에 한정되는 것은 아니다.Specifically, the cosmetic composition can be prepared in general emulsified formulations and solubilized formulations. For example, lotion, such as a softening lotion or a nourishing lotion; emulsions such as facial lotions and body lotions; creams such as nourishing creams, moisturizing creams, and eye creams; essence; makeup ointment; spray; gel; pack; sunscreen; makeup base; foundations such as liquid type, solid type or spray type; powder; makeup removers such as cleansing creams, cleansing lotions, and cleansing oils; Alternatively, it may be formulated as a cleaning agent such as a cleansing foam, soap, body wash, but is not limited thereto. In addition, the external preparation for skin may be formulated as an ointment, patch, gel, cream or spray, but is not limited thereto.
상기 화장료 조성물은 각각의 제형에 있어서 상기 필수성분 외에 제형의 종류 또는 사용 목적 등에 따라 본 발명에 따른 목적을 저해하지 않는 범위 내에서 다른 성분들이 적절히 배합될 수 있다.In the cosmetic composition, in addition to the essential components in each formulation, other components may be appropriately blended within the range that does not impair the purpose according to the present invention, depending on the type of formulation or purpose of use.
상기 화장료 조성물은 통상적으로 허용 가능한 담체를 포함할 수 있으며, 예컨대 유분, 물, 계면활성제, 보습제, 저급 알코올, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나, 이에 한정되는 것은 아니다.The cosmetic composition may include a conventionally acceptable carrier, for example, oil, water, surfactant, humectant, lower alcohol, thickener, chelating agent, colorant, preservative, fragrance, etc. may be appropriately mixed, but is limited thereto no.
상기 허용 가능한 담체는 제형에 따라 달리할 수 있다. 예컨대, 연고, 페이스트, 크림 또는 젤로 제형화될 때담체 성분으로서 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화아연 또는 이들의 혼합물이 사용될 수 있다.The acceptable carrier may vary depending on the formulation. For example, when formulated into an ointment, paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide or their Mixtures may be used.
상기 화장료 조성물은 파우더 또는 스프레이로 제형화될 때, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더 또는 이들의 혼합물이 사용될 수 있고, 스프레이의 경우 클로 로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진제를 더 포함할 수 있다.When the cosmetic composition is formulated as a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, or mixtures thereof may be used as a carrier component, and in the case of a spray, chlorofluoro It may further comprise a propellant such as hydrocarbon, propane, butane or dimethyl ether.
상기 화장료 조성물은 용액 또는 유탁액으로 제형화될 때, 담체 성분으로서 용매, 용해화제, 또는 유탁화제가 사용될 수 있고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-브틸글리콜 오일이 사용될 수 있고, 특히, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일 및 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 사용될 수 있다.When the cosmetic composition is formulated as a solution or emulsion, a solvent, solubilizer, or emulsifier may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl benzoate, propylene glycol, 1,3-Butylglycol oil may be used, and in particular, cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan may be used.
상기 화장료 조성물은 현탁액으로 제형화될 때, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리 옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 사용될 수 있다.When the cosmetic composition is formulated as a suspension, a liquid diluent such as water, ethanol or propylene glycol as a carrier component, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester; Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracanth and the like can be used.
상기 화장료 조성물은 최종 제품의 품질이나 기능에 따라 업계에서 통상적으로 사용되는 지방 물질, 유기용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉 쇄제, 킬레이트화제, 보존제, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 추가적으로 함유할 수 있다. 다만, 상기 보조제 및 그 혼합 비율은 본 발명에 따른 화장료 조성물의 바람직한 성질에 영향을 미치지 않도록 적절히 선택할 수 있다.The cosmetic composition may contain fatty substances, organic solvents, solubilizers, thickeners, gelling agents, softeners, antioxidants, suspending agents, stabilizers, foaming agents, and fragrances commonly used in the industry depending on the quality or function of the final product. , surfactants, water, ionic or nonionic emulsifiers, fillers, sequestering agents, chelating agents, preservatives, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, commonly used in cosmetics It may additionally contain adjuvants commonly used in cosmetic or dermatological fields, such as any other ingredients. However, the adjuvant and its mixing ratio may be appropriately selected so as not to affect the desirable properties of the cosmetic composition according to the present invention.
본 발명에 따라 제조된 인삼열매 발효물 또는 인삼열매 발효 정제물을 유효성분으로 포함하는 화장료 조성물은 인삼열매 발효물 또는 인삼열매 발효 정제물을 포함함으로써 콜라겐 분해 효소(Matrix Metalloproteinase-1)의 활성을 저해하고, 세포 내 콜라겐의 생성을 촉진하며, 표피 세포를 증식시킬 수 있다.The cosmetic composition comprising the fermented ginseng fruit or fermented ginseng fruit prepared according to the present invention as an active ingredient improves the activity of collagen degrading enzyme (Matrix Metalloproteinase-1) by including the fermented ginseng fruit or fermented ginseng fruit. It can inhibit, promote the production of intracellular collagen, and proliferate epidermal cells.
이하, 본 발명의 제조예 및 실험예를 들어 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail with reference to the preparation examples and experimental examples of the present invention.
제조예 1Preparation Example 1
건조된 인삼열매 200 g에 정제수 2 kg을 첨가하여 120℃에서 6시간 동안 열수 추출하였으며, 추출 후 당도 6 내지 8 birx인 인삼열매 열매 추출물을 사용하였다. 추출 후 락토바실러스 파라카세이(Lactobacillus paracasei, 한국세포주 은행에서 구입) 균주를 배양하여 상기 인삼열매 열매 추출물에 spectrophotometer로 측정한 농도가 1.0×109 cfu/ml인 배양액 1 중량%를 접종하고, 37℃에서 3일간 발효하였으며, 배양에 사용된 배지는 글루코오스 0.6 중량%, 효소 추출물 0.3 중량%, 소이톤 0.1 중량% 및 증류수로 구성된 배지를 사용하였다. 발효 후 발효액을 4,000 rpm, 10분 동안 원심분리하여 유산균과 배양액을 분리한 후, 배양액을 0.2 ㎛ 필터로 여과하여 인삼열매 발효물을 제조하였다.After adding 2 kg of purified water to 200 g of dried ginseng fruit, hot water extraction was performed at 120° C. for 6 hours. After extraction, a ginseng fruit extract having a sugar content of 6 to 8 birx was used. After extraction, the Lactobacillus paracasei (purchased from the Korea Cell Line Bank) strain was cultured, and the ginseng fruit extract was inoculated with 1 wt% of a culture solution having a concentration of 1.0×10 9 cfu/ml measured by a spectrophotometer, and 37°C. was fermented for 3 days, and the medium used for culture was a medium composed of glucose 0.6% by weight, enzyme extract 0.3% by weight, soytone 0.1% by weight, and distilled water. After fermentation, the fermentation broth was centrifuged at 4,000 rpm for 10 minutes to separate lactic acid bacteria and culture broth, and the culture broth was filtered through a 0.2 μm filter to prepare a fermented ginseng fruit.
제조예 2
상기 제조예 1에서 미생물로 바실러스 메틸로트로피쿠스(Bacillus methylotrophicus, Apep microrganism S001, 한국세포주 은행에서 구입)를 사용한 것을 제외하고는 동일하게 인삼열매 발효물을 제조하였다.A fermented ginseng fruit was prepared in the same manner as in Preparation Example 1, except that Bacillus methylotrophicus (Apep microrganism S001, purchased from Korea Cell Line Bank) was used as a microorganism.
제조예 3
상기 제조예 1에서 미생물로 바실러스 서브틸리스(Bacillus subtilis, Apep microrganism K007, 한국세포주 은행에서 구입)를 사용한 것을 제외하고는 동일하게 인삼열매 발효물을 제조하였다.A fermented ginseng fruit was prepared in the same manner as in Preparation Example 1, except that Bacillus subtilis (Apep microrganism K007, purchased from Korea Cell Line Bank) was used as a microorganism.
제조예 4
상기 제조예 1에서 미생물로 바실러스 메틸로트로피쿠스(Bacillus methylotrophicus, Apep microrganism S001, 한국세포주 은행에서 구입) 및 바실러스 서브틸리스(Bacillus subtilis, Apep microrganism K007, 한국세포주 은행에서 구입)를 1:1 중량부로 혼합한 혼합균주를 사용한 것을 제외하고는 동일하게 인삼열매 발효물을 제조하였다.As microorganisms in Preparation Example 1, Bacillus methylotrophicus (Bacillus methylotrophicus, Apep microrganism S001, purchased from Korea Cell Line Bank) and Bacillus subtilis (Bacillus subtilis, Apep microrganism K007, purchased from Korea Cell Line Bank) were 1:1 weight A fermented ginseng fruit was prepared in the same manner except for using a mixed strain mixed by part.
제조예 5
건조된 인삼열매 200 g에 70%(v/v) 에탄올 2 kg을 첨가하여 25℃에서 24시간 동안 추출하였으며, 추출 후 당도 6 내지 8birx인 인삼열매 열매 추출물을 사용하였다. 추출 후 락토바실러스 파라카세이(Lactobacillus paracasei, 한국세포주 은행에서 구입) 균주를 배양하여 상기 인삼열매 열매 추출물에 spectrophotometer로 측정한 농도가 1.0×109 cfu/ml인 배양액 1 중량%를 접종하고, 37℃에서 3일간 발효하였으며, 배양에 사용된 배지는 글루코오스 0.6 중량%, 효소 추출물 0.3 중량%, 소이톤 0.1 중량% 및 증류수로 구성된 배지를 사용하였다. 발효 후 발효액을 4,000rpm, 10분 동안 원심분리하여 유산균과 배양액을 분리한 후, 배양액을 0.2 ㎛ 필터로 여과하여 인삼열매 발효물을 제조하였다.2 kg of 70% (v/v) ethanol was added to 200 g of dried ginseng fruit and extracted at 25° C. for 24 hours. After extraction, a ginseng fruit extract having a sugar content of 6 to 8 birx was used. After extraction, the Lactobacillus paracasei (purchased from the Korea Cell Line Bank) strain was cultured, and the ginseng fruit extract was inoculated with 1 wt% of a culture solution having a concentration of 1.0×10 9 cfu/ml measured by a spectrophotometer, and 37°C. was fermented for 3 days, and the medium used for culture was a medium composed of glucose 0.6% by weight, enzyme extract 0.3% by weight, soytone 0.1% by weight, and distilled water. After fermentation, the fermentation broth was centrifuged at 4,000 rpm for 10 minutes to separate lactic acid bacteria and culture broth, and the culture broth was filtered through a 0.2 μm filter to prepare a fermented ginseng fruit.
제조예 6
상기 제조예 5에서 미생물로 바실러스 메틸로트로피쿠스(Bacillus methylotrophicus, Apep microrganism S001, 한국세포주 은행에서 구입)를 사용한 것을 제외하고는 동일하게 인삼열매 발효물을 제조하였다. A fermented ginseng fruit was prepared in the same manner as in Preparation Example 5, except that Bacillus methylotrophicus (Apep microrganism S001, purchased from Korea Cell Line Bank) was used as a microorganism.
제조예 7
상기 제조예 5에서 미생물로 바실러스 서브틸리스(Bacillus subtilis, Apep microrganism K007, 한국세포주 은행에서 구입)를 사용한 것을 제외하고는 동일하게 인삼열매 발효물을 제조하였다.A fermented ginseng fruit was prepared in the same manner as in Preparation Example 5, except that Bacillus subtilis (Apep microrganism K007, purchased from Korea Cell Line Bank) was used as a microorganism.
제조예 8
상기 제조예 5에서 미생물로 바실러스 메틸로트로피쿠스(Bacillus methylotrophicus, Apep microrganism S001, 한국세포주 은행에서 구입) 및 바실러스 서브틸리스(Bacillus subtilis, Apep microrganism K007, 한국세포주 은행에서 구입)를 1:1 중량부로 혼합한 혼합균주를 사용한 것을 제외하고는 동일하게 인삼열매 발효물을 제조하였다. In Preparation Example 5, Bacillus methylotrophicus (Bacillus methylotrophicus, Apep microrganism S001, purchased from Korea Cell Line Bank) and Bacillus subtilis (Bacillus subtilis, Apep microrganism K007, purchased from Korea Cell Line Bank) as microorganisms in Preparation Example 5 were 1:1 weight A fermented ginseng fruit was prepared in the same manner except for using a mixed strain mixed by part.
제조예 9
건조된 인삼열매 200 g에 정제수 2 kg을 첨가하여 120℃에서 6시간 동안 열수 추출하여 당도 6 내지 8birx인 인삼열매 열매 추출물을 제조하였다.To 200 g of dried ginseng fruit, 2 kg of purified water was added, and hot water extraction was performed at 120° C. for 6 hours to prepare a ginseng fruit extract having a sugar content of 6 to 8 birx.
제조예 10
건조된 인삼열매 200 g에 70%(v/v) 에탄올 2 kg을 첨가하여 25℃에서 24시간 동안 추출하여 당도 6 내지 8birx인 인삼열매 열매 추출물을 제조하였다.To 200 g of dried ginseng fruit, 2 kg of 70% (v/v) ethanol was added and extracted at 25° C. for 24 hours to prepare a ginseng fruit extract having a sugar content of 6 to 8 birx.
정제예refinement example
1) 상기 제조예 4에서 제조한 인삼열매 발효물에 n-헥산, 디클로로메탄, 에틸아세테이트 및 부탄올을 순차적으로 가하여 n-헥산 분획물, 디클로로메탄 분획물, 에틸아세테이트 분획물, 부탄올 분획물 및 물 분획물로 분리하여 분획물을 제조하였다.1) n-hexane, dichloromethane, ethyl acetate and butanol were sequentially added to the fermented ginseng fruit prepared in Preparation Example 4, and separated into an n-hexane fraction, a dichloromethane fraction, an ethyl acetate fraction, a butanol fraction and a water fraction. Fractions were prepared.
2) 분리된 물 분획물을 감압 농축한 후, 실리카 컬럼 크로마토그래피를 수행하였다. 이때 컬럼은 실리카 컬럼(Silica column)을 사용하였고, 이동상 용매는 증류수 CH2Cl2: Water 90 : 10, 80 : 20 순으로 1L 씩 변화시켜 진행하여 fr1(1), fr2(2), fr3(3), fr4(4), fr5(5), fr6(6-7), fr7(8-10), fr8(11), fr9(12), fr10(13-15)으로 분리하였다.2) After the separated water fraction was concentrated under reduced pressure, silica column chromatography was performed. At this time, a silica column was used as the column, and the mobile phase solvent was distilled water CH 2 Cl 2 : Water 90: 10, 80: 20 by changing 1L in the order fr1(1), fr2(2), fr3( 3), fr4(4), fr5(5), fr6(6-7), fr7(8-10), fr8(11), fr9(12), fr10(13-15).
3) 분리된 fr.1을 Prep. HPLC(C18 ODS column, 3ml/min)를 하여 정제하였다. 용매는 용매 A : Water in 0.1% TFA, 용매 B : 아세토나이트릴(ACN) in 0.1% TFA, 98:2 조건으로 진행하여 comp1을 인삼열매 발효 정제물에서 정제하였다.3) The separated fr.1 was prep. It was purified by HPLC (C18 ODS column, 3ml/min). Solvent A: Water in 0.1% TFA, Solvent B: Acetonitrile (ACN) in 0.1% TFA, 98:2 conditions were carried out, and comp1 was purified from the fermented ginseng fruit.
실험예 1Experimental Example 1
상기 제조예 1 내지 10에서 제조된 인삼열매 발효물의 피부 주름 개선 효과를 확인하기 위해 하기 방법에 따라 생체 외(in vitro) 콜라게나아제(collagenase) 활성 저해 실험을 진행하였고, 그 결과를 하기 표 1에 나타내었다.In order to confirm the skin wrinkle improvement effect of the fermented ginseng fruit prepared in Preparation Examples 1 to 10, an in vitro collagenase activity inhibition experiment was performed according to the following method, and the results are shown in Table 1 shown in
[실험 방법][Test method]
(1) 콜라겐을 인산 완충액에 녹여 준비한다(100 ppm). 이때 양성 대조군으로 아데노신을 같은 농도로 준비한다.(1) Prepare by dissolving collagen in phosphate buffer (100 ppm). At this time, adenosine is prepared at the same concentration as a positive control.
(2) 100 mM Tris-cl buffer, 100 mM CaCl2 및 0.25 mg/ml 콜라게나제가 포함된 mixture를 준비하고, 상기 각각의 시험물질 및 양성대조군을 상기 mixture에 5%(v/v)의 농도로 첨가하여 반응을 진행시킨다.(2) Prepare a mixture containing 100 mM Tris-cl buffer, 100 mM CaCl 2 and 0.25 mg/ml collagenase, and add each test substance and positive control to the mixture at a concentration of 5% (v/v) was added to proceed with the reaction.
(3) 25 mM 시트르산을 400 ㎕/tube 첨가하여 반응을 종료시킨다.(3) The reaction is terminated by adding 25 mM citric acid to 400 μl/tube.
(4) 이후 에틸아세테이트를 1.5 ㎖/tube 첨가하고, 볼텍싱(vortexing)한 후 상등액을 취하여 황산나트륨 150 mg/ep-tube에 옮기고, 볼텍싱 후 원심분리(10,000rpm, 3분)한다.(4) Then, 1.5 ㎖/tube of ethyl acetate is added, and after vortexing, the supernatant is taken and transferred to sodium sulfate 150 mg/ep-tube, and centrifuged after vortexing (10,000 rpm, 3 minutes).
(5) 상등액 300 ㎕/ep-tube를 취하여 석영 96well 플레이트에 옮긴 후 320 nm에서 흡광도를 측정한다.(5) Take 300 μl/ep-tube of the supernatant, transfer it to a quartz 96-well plate, and measure the absorbance at 320 nm.
상기 표 1을 참조하면, 모든 발효물(제조예 1 내지 8)에서 콜라게나제 억제능을 확인할 수 있으며, 발효하지 않은 경우(제조예 9 및 10)보다 콜라게나제 억제능이 우수함을 확인할 수 있다.Referring to Table 1, it can be seen that all fermented products (Preparation Examples 1 to 8) have a collagenase inhibitory ability, and it can be confirmed that the collagenase inhibitory ability is superior to that of the case without fermentation (Preparation Examples 9 and 10).
또한, 락토바실러스 속 균주를 사용한 경우(제조예 1 및 제조예 5)보다 바실러스 속 균주를 사용한 경우(제조예 2 내지 4 및 제조예 6 내지 8)의 콜라게나제 억제능이 우수하며, 단독 균주를 사용한 경우(제조예 1, 2, 3, 5, 6 및 7)보다 혼합균주를 사용한 경우(제조예 4 및 8)의 콜라게나제 억제능이 우수한 것을 알 수 있다.In addition, when using the Lactobacillus sp. strain (Preparation Example 1 and Production Example 5) than when using the Bacillus sp. strain (Preparation Examples 2 to 4 and Preparation Examples 6 to 8) is excellent in the collagenase inhibitory ability, the single strain It can be seen that the collagenase inhibitory ability in the case of using the mixed strain (Preparation Examples 4 and 8) is superior to the case of using (Preparation Examples 1, 2, 3, 5, 6 and 7).
또한, 열수 추출한 경우(제조예 1 내지 4)보다 에탄올 추출한 경우(제조예 5 내지 8)보다 콜라게나제 억제능이 우수한 것을 알 수 있다.In addition, it can be seen that the collagenase inhibitory ability is superior to that of the case of hot water extraction (Preparation Examples 1 to 4) than the case of ethanol extraction (Preparation Examples 5 to 8).
실험예 2Experimental Example 2
제조예 10의 인삼열매 열매 추출물, 제조예 8 인삼열매 발효물 및 정제예에서 분리한 분획물의 단백질 함량을 로우리방법(lowry methods)를 이용하여 측정하였으며, 측정 결과를 하기 표 2 및 도 2에 나타내었다.The protein content of the ginseng fruit extract of Preparation Example 10, the fermented ginseng fruit of Preparation Example 8 and the fractions isolated in Purification Example was measured using the lowry method, and the measurement results are shown in Table 2 and FIG. 2 below. It was.
(인삼열매 추출물)
(ginseng fruit extract)
(인삼열매 발효물)
(Fermented ginseng fruit)
(헥산, n-Hex)refinement example
(Hexane, n-Hex)
(디클로로메탄, CH2Cl2)refinement example
(dichloromethane, CH2Cl2)
(부탄올, n-BuOH)refinement example
(butanol, n-BuOH)
(물)refinement example
(water)
상기 표 2 및 도 2를 참조하면, 인삼열매 열매 추출물(제조예 10)에 비해 인삼열매 발효물(제조예 8)의 단백질 함량이 정량 값이 약 147% 증가하는 것을 확인할 수 있으며, 인삼열매 발효 분획물(정제예)은 물 분획물의 단백질 함량이 가장 높은 것을 확인할 수 있다.Referring to Table 2 and FIG. 2, it can be seen that the quantitative value of the protein content of the fermented ginseng fruit (Preparation Example 8) is increased by about 147% compared to the ginseng fruit extract (Preparation Example 10), and the ginseng fruit fermentation It can be confirmed that the fraction (purified example) has the highest protein content of the water fraction.
또한, 인삼열매 발효물(제조예 8)보다 인삼열매 발효 물 분획물 (정제예)의 단백질 함량(mg/ml)이 2.36배 이상인 것을 확인할 수 있다.In addition, it can be confirmed that the protein content (mg/ml) of the fermented ginseng fruit fraction (purified example) is 2.36 times or more than that of the ginseng fruit fermented product (Preparation Example 8).
실험예 3Experimental Example 3
상기 정제예에서 분리된 fr.1 내지 10 대하여 실리카겔 박막크로마토그래피(Thin Layer Chromatography, TLC)를 디클로로메탄 : 99.5%(v/v) 메탄올(2:1) 혼합 용매 하에 실시하였으며, 이에 따른 TLC 패턴을 도 3에 나타내었다.Silica gel thin layer chromatography (TLC) for fr.1 to 10 isolated in the above purification example was performed in a mixed solvent of dichloromethane: 99.5% (v/v) methanol (2:1), and the TLC pattern according to this is shown in FIG. 3 .
도 3을 참조하면, 분리된 물질을 확인한 결과 210 UV에서 확인할 수 있으며, lowry에서 함량을 확인한 결과 단백질임을 확인할 수 있고, 이에 따라 단백질 정제 조건을 확인할 수 있다.Referring to FIG. 3 , as a result of confirming the separated material, it can be confirmed at 210 UV, and when the content is checked at lowry, it can be confirmed that it is a protein, and thus protein purification conditions can be confirmed.
실험예 4Experimental Example 4
상기 정제예에서 분리된 물(물 층), fr.1, prep1에 포함된 단백질 함량을 로우리 방법(lowry methods)을 이용하여 측정하였으며, 측정 결과를 하기 표 3 및 도 4에 나타내었다.The protein content contained in water (water layer), fr.1, and prep1 separated in the purification example was measured using the lowry method, and the measurement results are shown in Tables 3 and 4 below.
(펩타이드 함량, mg/ml)Protein Quantitation
(peptide content, mg/ml)
상기 표 3 및 도 4를 참조하면, HPLC(High Pressure Liquid Chromatography)를 통한 분리정제 진행 시 단백질 함량이 높아짐은 확인하였으나, 일정수준 이상으로는 단백질 함량이 높아지지 않는 것을 확인할 수 있다.Referring to Table 3 and FIG. 4 , it was confirmed that the protein content increased during separation and purification through High Pressure Liquid Chromatography (HPLC), but it was confirmed that the protein content did not increase above a certain level.
실험예 6Experimental Example 6
제조예 4에 따른 인삼열매 발효물, 정제예의 물 층, fr.1 및 prep.1 내지 4에 포함된 타겟 펩타이드(Hexapeptide AP-1) 함량을 상기 정제예와 동일한 HPLC를 이용하여 측정하였으며, 측정 결과를 하기 표 4 및 도 5에 나타내었다.The content of the target peptide (Hexapeptide AP-1) included in the fermented ginseng fruit according to Preparation Example 4, the water layer of the purification example, fr.1 and prep.1 to 4 was measured using the same HPLC as in the purification example, and measured The results are shown in Table 4 and FIG. 5 below.
상기 표 4 및 도 5을 참조하면, 인삼열매 발효물(제조예 4) 및 prep.4(정제예)의 경우는 타겟 펩타이드가 나타나지는 않았으나, 상이한 펩타이드가 존재하였으며, prep 1 (정제예)의 경우 타겟 펩타이드의 함량이 HPLC함량 확인을 통해 93%까지 향상된 것을 확인할 수 있었고 이 결과를 도 6에 나타내었다.Referring to Tables 4 and 5, in the case of the fermented ginseng fruit (Preparation Example 4) and prep.4 (Purified Example), the target peptide did not appear, but different peptides were present, and prep 1 (Purified Example) In this case, it was confirmed that the content of the target peptide was improved to 93% through HPLC content confirmation, and the result is shown in FIG. 6 .
실험예 7Experimental Example 7
HPLC 정제 후 확보된 comp1 구조를 확인하기 위하여 하기 실험방법에 따라 실험을 진행하였고, 그 결과를 도 7에 나타내었다.In order to confirm the comp1 structure obtained after HPLC purification, an experiment was performed according to the following experimental method, and the results are shown in FIG. 7 .
[실험 방법][Test method]
100 ppm으로 시료를 준비한 후, Mass(FAB-Mass)를 이용하여 Mass를 측정하였다. 이후 600 MHz NMR(Agilent Technologies(DD2 600 MHz FT NMR))을 이용하여, 1H, 13C, HMBC, HMQC, COSY 및 DEPT를 측정하여 구조를 확인하였다.After preparing the sample at 100 ppm, the mass was measured using Mass (FAB-Mass). Then, using 600 MHz NMR (Agilent Technologies (DD2 600 MHz FT NMR)), 1H, 13C, HMBC, HMQC, COSY and DEPT were measured to confirm the structure.
도 7를 참조하면, Hexapeptide AP-1 경우 1H NMR와 13C NMR과 2D NMR을 통해 정확한 구조를 파악하였으며, 1H NMR에서 δ 1.260에서 CH3가 어려개 겹친 peak를 확인하였으며 , d3.7011 3.804에서 CH2의 피크들을 d4.237,4.197에서 CH의 피크를 확인하였다. 또한, DEPT를 통해 C * 6, CH * 3, CH2 * 3, CH * 3을 확인하여 총 CH, CH2, CH3의 개수를 파악하였으며, 2D-NMR을 통해 각 C, CH, CH2, CH3의 결합을 확인하였다. 이를 통해 FAB-Mass 통해 확인한 분자량인 403과 비교 확인하였을 때, Gly-Ala이 반복적으로 붙어 있는 구조임을 확인하였다. 그 후 펩타이드 합성을 진행하였으며, 합성된 펩타이드와 발효물에서 분리, 정제한 펩타이드를 HPLC를 통해 비교하여 동일한 시간대에 피크가 나오는 것을 확인하였다.Referring to Figure 7, in the case of Hexapeptide AP-1 , the exact structure was identified through 1 H NMR, 13 C NMR, and 2D NMR, and CH 3 at δ 1.260 in 1 H NMR was confirmed to have overlapped peaks, d3.7011 The peaks of CH2 at 3.804 and the peaks of CH at d4.237,4.197 were confirmed. In addition, by checking C * 6, CH * 3, CH2 * 3, CH * 3 through DEPT, the total number of CH, CH 2 , and CH 3 was identified, and each C, CH, CH 2 , Binding of CH 3 was confirmed. Through this, when compared with 403, which is the molecular weight confirmed through FAB-Mass, it was confirmed that Gly-Ala was repeatedly attached to the structure. After that, peptide synthesis was carried out, and it was confirmed that a peak appeared at the same time by comparing the synthesized peptide and the peptide separated and purified from the fermented product through HPLC.
실험예 8Experimental Example 8
Matrix methaloprotease-1(MMP-1, collagenase) 생성을 저해하는 물질은 콜라겐을 보호하여 피부조직의 기계적 특성을 유지시켜 탄력과 피부가 늘어지는 것을 방지하기 때문에 원료에 대한 MMP-1 생성을 저해하는 활성을 측정하여 활성을 갖는 원료는 주름을 개선하고 탄력 있는 피부를 위한 화장품 개발에 유용하게 사용될 수 있는 것으로 평가할 수가 있다. 이에, 상기 제조예 4의 인삼열매 발효물, 제조예 10의 인삼열매 열매 추출물 및 정제예의 분획물의 MMP-1 생성 저해능 시험을 하기와 같은 방법으로 진행하였고, 이에 대한 결과를 도 8에 나타내었다. 대조군으로 레티놀을 이용하였다.Substances that inhibit the production of matrix methaloprotease-1 (MMP-1, collagenase) protect collagen and maintain the mechanical properties of the skin tissue to prevent elasticity and sagging of the skin. By measuring the active ingredients, it can be evaluated that it can be usefully used in the development of cosmetics for wrinkle improvement and elastic skin. Accordingly, the MMP-1 production inhibitory ability test of the fermented ginseng fruit of Preparation Example 4, the ginseng fruit extract of Preparation Example 10 and the fractions of Purified Example was performed in the following manner, and the results are shown in FIG. 8 . Retinol was used as a control.
[실험 방법][Test method]
사람 진피섬유아세포 Human dermal fibroblst(HDF) 세포는 DMEM(Dulbecco's modified Eagle's media, Sigma)에 10% 우태아혈청(fetal bovine serum, Sigma)을 첨가한 배지로 37℃, 5% CO2 조건에서 배양하였다. 24-웰 플레이트에 2 X 105 cells/well의 농도로 세포를 배양하고 세포의 부착을 확인한 뒤, 대조군에는 아무것도 처리하지 않고 용매만 넣었으며, 디쉬에는 실험군과 대조군으로 레티놀을 10 ug/ml의 농도가 되도록 처리를 하였다. 각각의 디쉬에 시험물질을 가한 뒤 2일 동안 배양하였다. 2일 뒤, 배지를 채취하여 Matrix Metalloproteinase-1(MMP-1), Human,biotrak,ELISA kit (GE healthcare RPN2610)을 통해 MMP-1의 생성저해능을 측정하였다.Human dermal fibroblasts (HDF) cells were cultured in DMEM (Dulbecco's modified Eagle's media, Sigma) in a medium supplemented with 10% fetal bovine serum (Sigma) at 37°C and 5% CO 2 conditions. . After culturing the cells at a concentration of 2
도 8를 참조하면, 생성되는 MMP-1의 발현 양이 대부분의 실험군에서 줄어드는 것을 확인하였으며 실험군 내에서도 조성물 내 기능성 원료성분의 조합 및 조성물에 따라 차이가 있는 것으로 확인되었다. 특히 인삼열매 발효 후 분획 시 물층(정제예)에 가장 MMP-1 발현을 저해하는 물질이 많이 분포되어 있는 판단된다. 이러한 결과로부터 피부에 MMP-1생성을 유발하는 UV가 요인으로 적용되었을 때, 인삼열매 발효물 및 인삼열매 발효 정제물을 혼합하여 사용하는 것이 더 유용한 결과를 나타내어 MMP-1생성을 저해하여 피부의 피부노화을 억제할 수 있을 것으로 사료된다.Referring to FIG. 8 , it was confirmed that the amount of MMP-1 produced was decreased in most of the experimental groups, and it was confirmed that there was a difference according to the composition and combination of functional raw materials in the composition even within the experimental group. In particular, it is judged that most of the substances inhibiting MMP-1 expression are distributed in the water layer (purified example) during fractionation after fermentation of ginseng fruit. From these results, when UV that induces MMP-1 production on the skin is applied as a factor, it is more useful to use a mixture of fermented ginseng fruit and fermented ginseng fruit. It is thought to be able to suppress skin aging.
실험예 9Experimental Example 9
상기 제조예 4의 인삼열매 발효물, 정제예의 물층, fr1 및 comp1 (Hexapeptide AP-1)의 세포 내 콜라겐 생성능을 하기와 같은 방법으로 진행하였고, 이에 대한 결과를 도 9에 나타내었다. 대조군으로 형질전환 성장 인자 베타(transforming growth factor beta: TGFβ)를 사용하였다.The intracellular collagen-producing ability of the fermented ginseng fruit of Preparation Example 4, the water layer of the purified example, and fr1 and comp1 (Hexapeptide AP-1) was performed in the following manner, and the results are shown in FIG. 9 . As a control, transforming growth factor beta (TGFβ) was used.
[실험 방법][Test method]
시험에 사용할 사람 진피섬유아세포 Human dermal fibroblst(HDF) 세포는 Medium 106 (cascade biologics, M-106-500) 에 1X LSGS(Low Serum Growth Supplement, cascade biologics S-003-10)을 첨가한 배지로 37℃, 5% CO2 조건에서 배양하였다. 24-웰 플레이트에 1X 105 cells/well의 농도로 세포를 배양하고 세포의 부착을 확인한 뒤, 실험군과 대조군으로 TGFβ를 각각 1mg/ml 및 10μg/ml의 농도가 되도록 처리를 하였다. 각각의 디쉬에 시험물질을 가한 뒤 2일 동안 배양하였다. 2일 뒤, 배지를 채취하여 Procollagen Type I C-peptide(이하 PIP) EIA kit (takara MK101) 을 통해 Collagen 생성량을 측정하였다.Human dermal fibroblst (HDF) cells to be used for the test are medium 106 (cascade biologics, M-106-500) added with 1X LSGS (Low Serum Growth Supplement, cascade biologics S-003-10). 37 ℃, 5% CO 2 Incubated under conditions. Cells were cultured in a 24-well plate at a concentration of 1X 10 5 cells/well and cell adhesion was confirmed, and TGFβ was treated to a concentration of 1 mg/ml and 10 μg/ml, respectively, as an experimental group and a control group. After adding the test substance to each dish, it was cultured for 2 days. After 2 days, the medium was collected and the amount of collagen produced was measured using the Procollagen Type I C-peptide (hereinafter PIP) EIA kit (takara MK101).
도 9을 참조하면, 모든 실험군과 대조군에서 콜라겐 생성량이 증가하는 것을 확인하였고, 정제되지 않은 경우 (인삼열매 발효물)보다 정제된 경우(정제예 물층, fr1 및 comp1 (Hexapeptide AP-1)가 우수한 콜라겐 생성효과가 있음을 확인할 수 있고, 또한 가장 많이 정제된 comp1 (Hexapeptide AP-1) 가 가장 높은 콜라겐 생성효과가 있음을 알 수 있다.Referring to FIG. 9 , it was confirmed that collagen production increased in all experimental groups and control groups, and the purified (Purified Example water layer, fr1 and comp1 (Hexapeptide AP-1)) was superior to the unrefined (fermented ginseng fruit). It can be confirmed that there is a collagen production effect, and it can be seen that the most purified comp1 (Hexapeptide AP-1) has the highest collagen production effect.
이러한 결과로부터 피부에서의 collagen 생성을 촉진하는 성분이 인삼열매 열매 내에 다량 포함되어 있는 것으로 추측되며, 인삼열매 발효물 및 인삼열매 발효 정제물을 혼합하여 사용하는 것이 collagen 생성을 증가시켜 피부의 피부노화을 억제할 수 있을 것으로 사료된다.From these results, it is presumed that a large amount of ingredients that promote collagen production in the skin are contained in the ginseng fruit, and using a mixture of fermented ginseng fruit and fermented ginseng fruit can increase collagen production and reduce skin aging. It is believed that it can be suppressed.
실험예 10Experimental Example 10
정제예의 comp1의 세포 증식능을 확인하기 위해 하기와 같은 방법으로 실험을 진행하였고, 그에 대한 결과를 도 10 및 도 11에 나타내었다. 세포 증식능 실험은 MTT assay를 이용하여 측정하였다.In order to confirm the cell proliferation ability of comp1 of the purification example, the experiment was carried out in the following manner, and the results are shown in FIGS. 10 and 11 . Cell proliferation was measured using the MTT assay.
[실험 방법][Test method]
3T3세포 및 HACAT세포를 24웰 플레이트에 각 웰당 4 X 104 cells/24well의 세포수가 되도록 seeding 한 후 24시간 동안 37℃, 5% CO2조건으로 항온 배양하였다. PBS(phosphate buffer saline)로 2회 세척하고, 각각의 시료를 농도별(1mg~1ug/mL)로 처리하여 24시간 동안 항온 배양하였다. 배양 후 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 0.5% in DPBS(Dulbecco's Phosphate-Buffered Saline)를 배양 배지와 1:9(v/v)로 혼합하여 첨가한 후 2시간 동안 CO2 인큐베이터에서 배양한다. 이후 생성된 포르마잔(frmazan)을 DMSO(Dimethyl sulfoxide)에 녹여 ELISA를 이용하여 570nm에서 흡광도를 측정하였다. 3T3 cells and HACAT cells were seeded to a cell number of 4 X 10 4 cells/24well per well in a 24-well plate, and then incubated at 37° C., 5% CO 2 conditions for 24 hours. It was washed twice with PBS (phosphate buffer saline), and each sample was treated with each concentration (1mg~1ug/mL) and incubated for 24 hours. After incubation, 0.5% of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in DPBS (Dulbecco's Phosphate-Buffered Saline) was mixed with the culture medium at 1:9 (v/v). After addition, incubate in a CO 2 incubator for 2 hours. Then, the generated formazan (frmazan) was dissolved in DMSO (dimethyl sulfoxide) and absorbance was measured at 570 nm using ELISA.
도 10 및 도 11를 참조하면, HACAT 세포 및 3T3세포에 대하여, 저농도에서 고농도까지 처리한 1종의 펩타이드(comp1)이 농도 의존적으로 세포 증식능이 있는 것으로 확인되었으며 세포들의 현미경적인 관찰에서도 별다른 변화가 관찰되지 않았다.10 and 11, with respect to HACAT cells and 3T3 cells, it was confirmed that one type of peptide (comp1) treated from a low concentration to a high concentration had a cell proliferation ability in a concentration-dependent manner, and there was no significant change in the microscopic observation of the cells. not observed.
이를 통해 본 발명의 화장료 조성물은 피부 관련 세포에 독성이 전혀 없음을 알 수 있으며 피부 세포 증식효과가 있는 것으로 보인다. 따라서 본 발명의 화장료 조성물을 피부에 처리하여도 큰 영향을 끼치지 않으리라는 것을 예측할 수 있다.Through this, it can be seen that the cosmetic composition of the present invention has no toxicity to skin-related cells, and it appears to have a skin cell proliferation effect. Therefore, it can be predicted that even if the cosmetic composition of the present invention is treated on the skin, it will not have a significant effect.
실험예 11Experimental Example 11
정제예의 comp1의 열 및 광안전성을 확인하기 위하여 하기와 같은 방법으로 실험을 진행하였고, 그에 대한 결과를 도 12 및 도 13에 나타내었다.In order to confirm the thermal and photostability of comp1 of the tablet example, the experiment was conducted in the following manner, and the results are shown in FIGS. 12 and 13 .
[실험 방법][Test method]
시료가 각각 10 mg/mL이 되도록 각각의 시료를 50 mM Tris-HCl(pH 8.0) 완충용액에 용해하여 유리 바이알에 분주하여 넣은 후 50℃에서 4주간 보관하며 열에 의한 조성물 내 펩타이드의 손실을 측정하고 동일한 방법으로 일광 조건에서 안정성 여부를 측정하였다.Each sample is dissolved in 50 mM Tris-HCl (pH 8.0) buffer so that the sample is 10 mg/mL, aliquoted into a glass vial, and stored at 50° C. for 4 weeks to measure the loss of peptide in the composition due to heat. and stability under sunlight conditions was measured in the same manner.
도 12 및 도 13를 참조하면, 열에 의한 펩타이드 손실을 측정하고 일광 조건에서 안정성 여부를 측정한 결과, 모든 1종의 펩타이드(comp1)에서 4주까지 단지 10% 미만의 펩타이드 손실을 나타내어 열 및 일광 보관 기간에 있어 높은 안정성을 갖는다는 것을 확인하였다.12 and 13, as a result of measuring the loss of the peptide due to heat and measuring the stability in sunlight conditions, all one peptide (comp1) showed less than 10% peptide loss up to 4 weeks, so that heat and sunlight It was confirmed that it has high stability in the storage period.
화장료 조성물 제조예Cosmetic composition preparation example
크림 타입 조성물은 아래와 같은 방법을 제조하였다. 크림 타입 조성물에는 앞의 Hexapeptide AP-1을 조성물의 1% 중량비로 포함하여 제형을 구성하였다(하기 표 5 참조).The cream-type composition was prepared in the following way. In the cream type composition, the formulation was constituted by including the above Hexapeptide AP-1 in a weight ratio of 1% of the composition (see Table 5 below).
1) [수상B] 제조1) Preparation of [Aqueous B]
물을 가온하여 60 내지 70℃로 교반 하면서 분말상 원료를 순차적으로 서서히 투입하여 점증이 될 때 까지 디스퍼 믹서로 교반하여 고르게 풀어준 후, 식혀준다. 공정 용이성을 위해 사전에 준비해둔다.Water is heated and stirred at 60 to 70° C., and powdered raw materials are sequentially added sequentially, stirred with a disper mixer until thickened, and dissolved evenly, and then cooled. Prepare in advance for ease of processing.
2) [수상A] 제조2) Preparation of [Aqueous A]
분말상 원료를 글리세린에 충분히 함침 시킨 후, 물을 첨가하여 50 내지 60℃로 가온하여 디스퍼 믹서로 골고루 녹여준다.After the powdery raw material is sufficiently impregnated with glycerin, water is added and heated to 50 to 60° C. to dissolve evenly with a disper mixer.
3) [수상A] + [수상B] 혼합 교반 제조3) [Water A] + [Water B] Mix Stirring Preparation
미리 준비해 둔 수상B를 수상A에 첨가하여 고르게 섞어주면서 가온한다. 65 내지 75℃가 유지될 수 있도록 준비해둔다.Add pre-prepared aqueous phase B to aqueous phase A and warm while mixing evenly. Prepare to be maintained at 65 to 75 ℃.
4) [유상] 혼합 교반 제조4) [Oil phase] Mixed and stirred manufacturing
각 원료를 개별 비이커에 평량하여 가온 교반하여 녹여준다. (80℃ 이상) 녹여진 상은 75℃ 이상 온도가 유지될 수 있도록 준비해둔다.Each raw material is weighed in a separate beaker and melted by heating and stirring. (Above 80℃) Prepare the melted phase to maintain a temperature of 75℃ or higher.
5) 전체 크림 제조5) Whole cream preparation
준비된 수상 혼합물에 유상을 서서히 투입 첨가하여 약 10분간 강하게 교반(6,000 rpm)하여 유화 공정을 진행한다. 이때 온도는 65 내지 75℃로 유지할 수 있도록 한다.The oil phase is slowly added to the prepared aqueous mixture and stirred vigorously (6,000 rpm) for about 10 minutes to proceed with the emulsification process. At this time, the temperature is to be maintained at 65 to 75 ℃.
완료 후, 첨가제 A를 준비하여 pH 조정 및 중화 공정을 진행한다. 이 때, 내용물의 점도가 상승하므로, 강하게(6,000 rpm) 골고루 5분 이상 교반해준다.After completion, the additive A is prepared and the pH adjustment and neutralization process is performed. At this time, since the viscosity of the contents rises, stir vigorously (6,000 rpm) evenly for 5 minutes or more.
50℃ 이하로 내용물이 식으면 첨가제 B를 넣고 서서히 2분 정도 섞어주며(3,000 내지 4,000 rpm), 40℃ 이하가 되면 첨가제 C와 첨가제 D를 순차적으로 첨가하여 2분 정도 천천히(3,000 내지 4,000 rpm) 교반 후, 탈기/여과 공정을 거쳐 내용물을 수거한다.When the content cools below 50°C, add Additive B and mix slowly for about 2 minutes (3,000 to 4,000 rpm). When the temperature is below 40°C, add Additive C and Additive D sequentially and slowly for about 2 minutes (3,000 to 4,000 rpm) After stirring, the contents are collected through a degassing/filtration process.
완료 후, pH 조정 및 중화 공정을 진행한다. 이 때, 내용물의 점도가 상승하므로, 강하게(6,000 rpm) 골고루 5분 이상 교반해준다.After completion, the pH adjustment and neutralization process is performed. At this time, since the viscosity of the contents rises, stir vigorously (6,000 rpm) evenly for 5 minutes or more.
50℃ 이하로 내용물이 식으면 보존제를 넣고 서서히 2분 정도 섞어주며(3,000 내지 4,000 rpm), 40℃ 이하가 되면 인삼열매 펩타이드와 향료를 첨가하여 2분 정도 천천히(3,000 내지 4,000 rpm) 교반 후, 탈기/여과 공정을 거쳐 내용물을 수거한다.When the content cools below 50℃, add a preservative and mix slowly for about 2 minutes (3,000 to 4,000 rpm). When the temperature is below 40℃, add ginseng berry peptide and flavorings and stir slowly (3,000 to 4,000 rpm) for about 2 minutes. The contents are collected through a degassing/filtration process.
제조된 크림은 저온(4℃)과 고온 (50℃), 상온 (25℃), 일광조건에서 보관하여 크림의 안정성을 확인하였으며 모든 조건에서 4주 동안 크림의 변색, 변취, 상변화, pH 변화와 같은 현상들이 발견되지 않았으며, 이를 통해,크림의 안정성이 유지되는 것을 확인하였다. 특히 인삼열매 펩타이드의 안정성이 유지되어 HPLC 분석 결과 모든 조건에서 4주 동안 90% 이상의 함량이 유지되는 것을 확인하였다(하기 표 6 참조). The prepared cream was stored at low temperature (4 ℃), high temperature (50 ℃), room temperature (25 ℃), and sunlight conditions to check the stability of the cream. Discoloration, discoloration, phase change, and pH change of the cream for 4 weeks under all conditions Such phenomena were not found, and through this, it was confirmed that the stability of the cream was maintained. In particular, the stability of the ginseng fruit peptide was maintained, and as a result of HPLC analysis, it was confirmed that the content was maintained at 90% or more for 4 weeks under all conditions (see Table 6 below).
이상에서 설명한 본 발명의 바람직한 실시예들은 기술적 과제를 해결하기 위해 개시된 것으로, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명의 사상 및 범위 안에서 다양한 수정, 변경, 부가 등이 가능할 것이며, 이러한 수정 변경 등은 이하의 특허청구범위에 속하는 것으로 보아야 할 것이다.Preferred embodiments of the present invention described above are disclosed to solve the technical problem, and various modifications, changes, additions, etc. will be possible within the spirit and scope of the present invention by those skilled in the art to which the present invention pertains. , such modifications and changes should be regarded as belonging to the following claims.
Claims (11)
상기 발효는 30 내지 50℃에서 2 내지 4일간 수행되는 것을 특징으로 하는 방법.According to claim 1,
The fermentation method, characterized in that it is carried out at 30 to 50 ℃ 2 to 4 days.
상기 균은 바실러스 속(Bacullus sp.) 균인 것을 특징으로 하는 방법.According to claim 1,
The bacteria is a method, characterized in that the bacteria of the genus Bacillus ( Bacullus sp.).
상기 기능성 펩타이드는 용매 분획 및 크기 배제 크로마토그래피를 통해 수득되는 것을 특징으로 하는 방법.According to claim 1,
The method, characterized in that the functional peptide is obtained through solvent fractionation and size exclusion chromatography.
상기 기능성 펩타이드는 (글리신-알라닌)n(n은 2 내지 10의 정수)의 서열을 포함하는 것을 특징으로 하는 방법.5. The method of claim 4,
The functional peptide is (glycine-alanine) n (n is an integer from 2 to 10) The method characterized in that it comprises a sequence.
상기 기능성 펩타이드는 글리신-알라닌-글리신-알라닌-글리신-알라닌의 서열을 포함하는 것을 특징으로 하는 방법.6. The method of claim 5,
The method, characterized in that the functional peptide comprises the sequence of glycine-alanine-glycine-alanine-glycine-alanine.
상기 기능성 펩타이드는 피부 주름 개선 및 항노화 기능을 갖는 것을 특징으로 하는 방법.According to claim 1,
The functional peptide method, characterized in that it has a skin wrinkle improvement and anti-aging function.
상기 기능성 펩타이드는 피부세포 생장을 촉진하여 피부세포의 재생속도를 증가시키는 기능을 갖는 것을 특징으로 하는 방법.According to claim 1,
The method characterized in that the functional peptide has a function of increasing the skin cell regeneration rate by promoting skin cell growth.
상기 기능성 펩타이드는 인간 섬유아세포주 내 콜라겐 생성을 촉진하고, 콜라겐 분해효소(MMP-1)의 활성을 억제하여 피부 주름 개선 기능을 갖는 것을 특징으로 하는 방법.According to claim 1,
The functional peptide promotes collagen production in human fibroblasts, and inhibits the activity of collagen degrading enzyme (MMP-1), characterized in that it has a skin wrinkle improvement function.
상기 인삼열매 발효물 및 상기 기능성 펩타이드는 인간 피부 각질 세포주 증식 촉진 기능을 갖는 것을 특징으로 하는 방법.According to claim 1,
The method, characterized in that the fermented ginseng fruit and the functional peptide have a function of promoting the proliferation of human skin keratinocytes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190173816A KR102628237B1 (en) | 2019-12-24 | 2019-12-24 | Preparing method of highly functional peptide derived from natural fermentation extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190173816A KR102628237B1 (en) | 2019-12-24 | 2019-12-24 | Preparing method of highly functional peptide derived from natural fermentation extracts |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210081645A true KR20210081645A (en) | 2021-07-02 |
KR102628237B1 KR102628237B1 (en) | 2024-01-23 |
Family
ID=76897101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190173816A KR102628237B1 (en) | 2019-12-24 | 2019-12-24 | Preparing method of highly functional peptide derived from natural fermentation extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102628237B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006052146A (en) * | 2004-08-10 | 2006-02-23 | Ichimaru Pharcos Co Ltd | Beautifully whitening agent |
KR20150084397A (en) * | 2014-01-14 | 2015-07-22 | 한국식품연구원 | Composition for whitening containing fermented ginseng seed oil |
KR20180090594A (en) * | 2017-02-03 | 2018-08-13 | 한국식품연구원 | Novel Bacillus subtilis 4-1-1 and method for fermented ginseng using the same |
KR20200010468A (en) * | 2017-05-24 | 2020-01-30 | 노파르티스 아게 | Antibody-Cytokine Implanted Proteins and Methods of Use in Cancer Treatment |
-
2019
- 2019-12-24 KR KR1020190173816A patent/KR102628237B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006052146A (en) * | 2004-08-10 | 2006-02-23 | Ichimaru Pharcos Co Ltd | Beautifully whitening agent |
KR20150084397A (en) * | 2014-01-14 | 2015-07-22 | 한국식품연구원 | Composition for whitening containing fermented ginseng seed oil |
KR20180090594A (en) * | 2017-02-03 | 2018-08-13 | 한국식품연구원 | Novel Bacillus subtilis 4-1-1 and method for fermented ginseng using the same |
KR20200010468A (en) * | 2017-05-24 | 2020-01-30 | 노파르티스 아게 | Antibody-Cytokine Implanted Proteins and Methods of Use in Cancer Treatment |
Non-Patent Citations (1)
Title |
---|
Genbank BAK20024(2011.04.29.)* * |
Also Published As
Publication number | Publication date |
---|---|
KR102628237B1 (en) | 2024-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100773856B1 (en) | Composition comprising an extract of siraitia grosvenori or triterpene compound isolated therefrom showing anti-wrinkle activity | |
KR20180034085A (en) | Composition for hair or scalp comprising lysate of Lactobacillus plantarum | |
KR20190063549A (en) | Cosmetic Composition Comprising Bamboo Fermented Extract | |
KR102154927B1 (en) | A cosmetic composition for anti-aging, anti-oxidant, skin regeneration comprising chlorogenic acid, ferulic acid, resveratrol, and Streptococcus thermophilus fermented extract | |
KR102119524B1 (en) | Cosmetic composition comprising the extract of fermented Sprout leaf/stem ginseng for skin anti-wrinkle effect and producing method thereof | |
KR101854444B1 (en) | A cosmetic composition for the prevention and improvement of striae distensae containing a extract of cynara scolymus | |
KR102344703B1 (en) | Method of Trapa Natans ferments, a composition for improving skin wrinkles and anti-aging containing the Trapa Natans fermentation product or peptide produced therefrom as an active ingredient and a composition for improving skin aging comprising a fermented product | |
KR102475100B1 (en) | Preparing method of highly functional peptide derived from keratinocyte protein | |
KR102628237B1 (en) | Preparing method of highly functional peptide derived from natural fermentation extracts | |
KR102344701B1 (en) | Cosmetic composition having high functional natural fermentation extracts | |
TWI706792B (en) | Use of skunk cabbage extract or its fraction | |
KR20190081627A (en) | Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder | |
KR20160003918A (en) | Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts | |
KR100466862B1 (en) | Composition for External Skin Application containing Hedyotis Diffusa Willd Extract | |
KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract | |
KR20180034086A (en) | Composition for hair or scalp comprising lysate of Lactobacillus sakei | |
KR102488533B1 (en) | Preparing method of highly functional anti-inflammatory component drived from Glycine max Merr. fermentation extracts and cosmetic composition using the same | |
KR20200084846A (en) | A composition for promoting the differentiation of human adipose derived stem cell | |
KR20190130543A (en) | Composition for improving wrinkle comprising Symplocarpus foetidus extract or fractions thereof | |
KR102344704B1 (en) | Preparing method of natural fermentation extracts and use having improved contents of high functional meterials | |
KR100714172B1 (en) | Cosmetic composition having the anti-wrinkle activity | |
KR102376616B1 (en) | Mugwort fermentation product and a manufacturing method for improving the active ingredient content of the mugwort fermentation produced therefrom, and a cosmetic composition comprising a composition and fermented product effective in improving skin wrinkles and anti-aging containing the same as an active ingredient | |
KR20190124351A (en) | Composition comprising extract of Prasiola japonica for skin whitening | |
KR20230076564A (en) | Preparing method of Ligustri fructus ferment filtrate drived high functional anti-inflammation, anti-aging substances and cosmetic composition using the same | |
KR20120076168A (en) | Skin antiaging agent and composition for skin antiaging comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |